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ABSTRACT

The unique properties of CNTs lead CNTs attractive in biological engineering
applications. It is expected to use CNT based biomaterials for clinic use in the near
future. CNTs can be used to tune cellular fate through bother extracellular pathway and
intracellular pathway. CNT based biomaterials has been applied into bone, nerves, and
cardiovascular system. There has also been progress in the use of CNTs in controlling
cellular alignment, to enhance tissue regeneration, growth factor delivery and gene
delivery.
Pluripotent stem cells (hPSCs) offer a promising tool in tissue engineering
strategies, as their differentiated derivatives can be used to reconstruct most biological
tissues. These approaches rely on controlling the extracellular and intracellular cues that
tune the ultimate fate of hPSCs. In this context, significant effort has gone to parse out
the role of conflicting matrix-elicited signals (eg. topography and elasticity) in regulation
of macroscopic characteristics of cells (eg. shape and polarity). A critical hurdle lies in
our inability to recapitulate the nanoscale spatiotemporal pattern of these signals. We
used CNTs as a tool to tune nanoscaled architecture in cellular microenvironment in
Chapter 2 and Chapter 3. After recapitulating the basic understanding of how CNT
pattern controlling cellular polarization and human embryonic stem cell attachment in 2D
substrate in Chapter 2, we took a step forward by developing a porous scaffold with
appropriate mechanical strength and controllable surface roughness for bone repair in
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chapter 3. We found that the incorporation of CNTs led to an enhanced surface roughness
and mechanical strength of CNT-PLGA composites, which led significantly higher rate
of osteogenic differentiation of osteoblasts on CNT/PLGA scaffolds compared to the
control PLGA scaffold. All these basic understanding lead us to enhance the utility and
efficacy of using CNTs for directing stem cell fate by both 2D and 3D substrate.
On the other hand, cancer has arisen to be of the most prominent health care
issues across the world in recent years. Doctors have used physiological intervention as
well as chemical and radioactive therapeutics to treat cancer thus far. As an alternative to
current methods, gene delivery systems with high efficiency, specificity, and safety that
can reduce side effects such as necrosis of tissue are under development. Although viral
vectors are highly efficient, concerns have arisen from the fact that viral vectors are
sourced from lethal diseases. With all this in mind, rod shaped nano-materials such as
CNTs have become an attractive option for drug delivery due to the enhanced
permeability and retention effect in tumors as well as the ability to penetrate the cell
membrane. In Chapter 4, we successfully engineered PLGA functionalized CNTs to
reduce toxicity concerns, provide attachment sites for a pro-apoptotic protein, caspase-3
(CP3), and tune the temporal release profile of CP3 within bone cancer cells. Our results
showed that CP3 was able to attach to functionalized CNTs, forming CNT-PLGA-CP3
conjugates. We show this conjugate can efficiently transduce cells at dosages as low as
0.05 g/ml and suppress cell proliferation up to a week with no further treatments.
Overall, our results showed CNTs were promising to tune cell fate both externally
and internally.
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CHAPTER 1

Introduction: Carbon Nanotubes in Biomedical Engineering Applications

1.1.

Carbon nanotubes
Carbon nanotubes (CNTs) were first discovered by Iijima and Baughman [1, 2]. A

single CNT is one or multiple layers of graphene sheets which roll up. Depending on the
number of the graphene sheets, CNTs are mainly categorized into single wall carbon
nanotubes (SCNTs) and multi wall carbon nanotubes (MCNTs) (Figure 1. 1) [3]. SCNTs
(Figure 1. 1A) has a diameter close to 1 nm with a varied length from nanometer to
centimeters. There are two models for MCNTs (Figure 1. 1B): one is Russian doll model,
while the other is parchment model. For Russian doll model, graphene sheets are
arranged in concentric cylinders. For the parchment model, a single sheet of graphene is
rolled up with several walls of grapheme sheets, like a scroll of newspaper. The interlayer
of distance for MCNTs is approximately 0.34 nm for those two models of CNTs [3]. The
Russian doll model are more commonly seen. In particular, double wall CNTs count for a
special subcategory in MCNTs. It has a similar property as SCNTs, but its chemical
resistance is more close to MCNTs [3, 4]. Besides these two major categories, there are
also new categories existed since 1990s: torus CNTs [5], nanobud CNTs [6], graphened
CNTs , nitrogen doped CNTs, peapod CNTs [7], cup stacked CNTs, extreme CNTs, etc.
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Figure 1. 1 Illustration of SCNT and MCNT. A. SCNT which has only a layer
of graphene. B. Russian doll model MCNT, several layer of tubes were
concentric arranged to form a MCNT.
Both CNT categories exhibit extraordinary chemical and physical properties.
CNTs hold unique physical and chemical properties: such as high surface to volume ratio,
high modulus, super electrical and thermal conductivity, super hydrophobic and inertia
[8]. Owing to CNTs’ extraordinary thermoconductivity, electroconductivity and
mechanical property, CNTs find their applications as additives in structural materials
such as golf stub, boat, aircraft, bicycles etc. Other than that, CNTs are extremely
attractive in composite materials [9, 10], electrical device [11-14], hydrogen storage [15,
16], biomedical engineering [17-22], etc.. We are extremely interested in using CNTs in
biomedical engineering applications.

1.1.1. Size
CNTs are nanosize materials. CNTs usually have a diameter smaller than 50 nm
depends on the numbers of the graphene layers [23]. The length of CNTs are varied
depending on the fabrication techniques and ranging from nanometers to even
centimeters [24]. However, the diameters of CNTs are more stable at the range of several
to several tens of nanometers, constructing as high aspect ratio as 132,000,000:1,
Therefore, CNTs shape like a needle, facilitating the cellular penetration. Meanwhile,
CNTs also maintain high ratio of surface area to volume, resulting a higher loading
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capacity. Relying on those properties, CNTs could be very efficient in trafficking
biological cargoes in biomedical engineering application.

1.1.2. Mechanical Strength
CNTs are one of the strongest and stiffest materials in the world in terms of
tensile modulus and elastic modulus. Graphite, which has a similar structure as
graphene, had an in-plane modulus of 1.06 TPa. Considering CNTs are layers of
graphene, CNT should display a similar stiffness [25]. Therefore, a couple of groups
focused on attenuating mechanical property of CNTs. Since 1990s, a number of groups
have conducted tests to discover the mechanical strength of CNTs. They found that the
modulus were ranging from tens to hundreds of GPa. With technique developed, it has
been demonstrated the Yong’s modulus of a single CNT was approximately 1 TPa [2629], which was 5 times than stainless steel. Note that CNTs are extremely light that its
density is approximately 1.4 g×cm-1, CNTs’ specific strength can reach 4.8×104
KN×m×Kg-1, which is 3000 times than high carbon steel. CNTs also had a high elastic
modulus ~50GPa, with a ~15 % elongation at break. However, CNTs bundles were not
as strong as individual CNTs. The weak shear interactions between CNTs and CNT
layers led the mechanical strength at GPa level. CNTs’ hollow structure and high aspect
ratio also led CNTs to undergo buckling rather than elastic deformation. What’s
interesting was that CNT bundle would only withstand a pressure lower than 25 GPa
[30]. All those data were usually obtained in axial direction of CNTs. The strength of
CNTs in radial directions were believed to be softer than its axial direction, which was
confirmed by AFM in the range of several GPa [31, 32]. Take a step forward, how do
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CNTs maintain such a strong property? The answer is because their unique molecular
structure. The carbon atoms which make CNTs up are bound by covalent sp2 bond,
which are stronger than sp3 hybridization found in alkanes and diamonds.
Overall, CNTs can be used to strengthen the mechanical properties of composite
materials as we mentioned above. However, particularly, CNTs were also used to
enhance the mechanical property for bone tissue engineering by directly injection into
and indirectly contact to bone tissue relying on CNTs’ super mechanical performance
[33, 34].

1.1.3. Electrical property

Figure 1. 2 m, n indices to describe the
electrical nature of carbon nanotubes.
Take the origin carbon as the number 1
carbon, draw vector a1 to atom 3 and
draw vector a2 to atom 5. Coming from
A to B, the number of atoms coming in
a1 and a2 directions are m and n.
The electrical property of CNTs is based on how the graphene sheet is rolled up.
The nature of the rolling up of CNTs is described using the indices (m, n) (Figure 1. 2).

4

In general, in a single phenol ring of CNTs, take the origin carbon as the number 1
carbon, draw a vector a1 to atom 3 and draw another vector a2 to atom 5. Coming from
A to B, the number of atoms coming in a1 and a2 directions are m and n. For SCNTs, if
m=n, the nanotube is described as armchair tube, which carbon patterns like an arm
chair. If m or n equals zero, the CNTs form a zig-zag pattern. All the other cases of the
indices refer as chiral tubes [35]. These indices can be used to predict the electrical
properties of CNTs.

Particularly, for the case of armchair pattern (m=n), CNTs

exhibited metallic property with a band gap of zero eV. For the case of m-n≠3, CNTs
were semi conductive with a band gap of approximately 0.5 eV. For the case of m-n=3,
CNTs were semi metallic with a band gap of approximately 10 meV [35]. Based on
these electrical properties, CNTs were able to be used as a chemical sensor, to monitor
the environmental change, control chemical process, pre-screen diseases [36, 37]. For
MCNTs, the electrical property was determined by each single layer of graphene sheets.

1.1.4. Optical properties
The optical properties of CNTs refer to absorption, photoluminescence and
Raman spectrum. These optical properties allow us to characterize or detective CNTs
quickly and nondestructively. These optical properties of CNTs derive from CNTs’
electronic transition within one-dimensional density of states (DOS) [38]. Note that a
single CNT can be considered as a one dimensional material. It should hold a typical
feature of one-dimensional crystals. That is their DOS is not a continuous function of
energy as a 3 dimensional material has, but it descends gradually and then increases in a
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discontinuous spike. Those sharp peaks find in one-dimensional materials are called Van
Hove singularities.
Due to Van Hove singularities, CNTs preserve 3 major remarkable optical
properties: (A) Optical transitions occur between the cross over transitions v1 - c1
and v2 - c2. However, these crossover transitions were dipole-forbidden, thus were
extremely weak and could only possibly be observed by using cross-polarized optical
geometry [39]. Note these crossover transitions of semiconducting or metallic CNTs are
traditionally labeled as S11, S22, M11, etc., or, if the conductivity of CNTs is unknown or
unimportant, as E11, E22, etc.. (B) Considering that the energies between the Van Hove
singularities depends on CNT structure. The optoelectronic properties of CNTs can be
tuned and controlled by varying CNT structure, Such designing ability has been
experimentally demonstrated by using UV illumination of polymer-dispersed CNTs [40].
(C) CNTs had rather sharp (~10 meV) and strong optical transitions. It is relatively easy
to selectively excite CNTs having certain (n, m) indices, therefore giving us the chance
to detect optical signals from that specific type of CNTs.
Optical absorption in CNTs originates from electronic transitions from crossover
transitions. The transitions are relatively sharp and can be used to identify specific CNT
types (m,n indices). However, it is not optimistic to distinguish different CNT types in a
CNT mixture. This is because that the sharpness of the gap deteriorates with increasing
energy. Many CNTs had very similar E22 or E11 energies, significant overlap of different
types of CNTs occurred in absorption spectra [41-44]. Furthermore, CNTs were close to
a black body (absorbance equals to 1) as well. For instance, vertically aligned SCNT
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array could have absorbance of 0.98–0.99 from the far-ultraviolet (200 nm) to farinfrared (200 μm) wavelengths [45].
Raman spectroscopy requires very small amount of sample but still has good
spatial resolution (~0.5 micrometers) and sensitivity for SCNT. The data obtained from
Raman spectroscopy would also examine the purity as well. Consequently, Raman
spectroscopy is becoming the most popular technique to characterize CNTs. Moreover,
what put Raman scattering more attractive for SCNT is the resonant property would
provide more applications in biomedical engineering [46, 47].

1.1.5. Thermal properties
All types of CNTs are good thermal conductor along tube direction as well.
Measurement has shown that SCNT had a thermal conductivity of 3500 W×m-1×K-1 at
room temperature. This was almost 10 times of the thermal conductivity of copper (385
W×m-1×K-1). What made SCNT’s thermal properties more attractive was that the
thermal conductivity along the radial direction was only 1.52 W×m-1×K-1, similar as soil.
Considering CNT were very stable up to 2800 oC in vacuum and 750 oC in air, CNTs
could be potentially used in one direction heat transfer [48, 49].

1.1.6. Hydrophobicity
CNTs are super hydrophobic materials as well [50]. Hydrophobicity is benefit in
waterproof applications. However, hydrophobicity is usually the main cause of intrinsic
toxicity of CNTs, leading cell to necrosis. Pristine CNTs would also tend to accumulated
and agglomerated due the hydrophobic interaction in water phase [51]. Therefore, to
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utilize CNTs in biomedical engineering applications, the functionalization of CNTs were
usually required.

1.2.

Functionalization of carbon nanotubes
As we mentioned above, the hydrophobicity of CNTs need to be changed to

hydrophilic in order to reduce the intrinsic toxicity of CNTs. Another reason for to do so
is that CNTs requires functionalization to be able to disperse in biological environment.
In general, the functionalization of CNTs can be categorized into covalent and noncovalent [52]. Non-covalent binding relies on the interactions between CNTs and
linkers. Covalent binding relies on chemical reactions to add reactive groups to CNTs
which facilitate further modifications such as protein/polymer conjugation.

1.2.1. Non-covalent functionalization of carbon nanotubes
For non-covalent functionalization of CNTs, pristine CNTs remain intact and
there is no atomic damage on either sidewall or terminal of CNTs. The dominant
interaction between CNTs and their adducts is π-π stacking [53]. Aromatic molecules
can be immobilized on the poly-aromatic graphitic surface of CNTs due to π-π stacking
(Figure 1. 3 upper panel). For instance, Pyrene derivatives were used to stabilize CNTs
from aggregation [54]. DNA and RNA were also able to immobilize CNTs due to the ππ stacking between nucleobase and CNTs [55, 56]. Moreover, proteins could be
functionalized on CNTs by interaction between benzene groups and CNT sidewall.
Besides π-π stacking, van der Waals forces and hydrophobic interaction are other key
forces for CNTs and adducts. For example, amphiphiles were used to suspend CNTs in
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water phase [57-59]. The hydrophobic methylene chain wrap over the CNTs Figure 1. 3
bottom panel) due to hydrophobic interaction. The hydrophobic backbone adhere to the
body of CNTs and the hydrophilic water-soluble head enhance the ability of CNT
conjugates to disperse in aqueous solution. Tween-20, Triton X-100 and pluronic
triblock polymers, were used to reduce protein binding or to obtain a well suspended
CNTs water solution. This non-covalent binding allows CNTs to be able to conjugate a
variety of cargoes which have biological function. The newly formed biological
conjugates can deliver these cargo into a living cell. There is another key advantage for
non-covalent binding. That is the structure of CNTs are not broken down, which let noncovalent bounded CNTs preserve their unique physical and chemical properties.
However, there are also critical concerns that A) non-covalent bounded molecules are
more easily detached from CNTs; B) biological molecules are tending to be degraded;
and C) amphiphilic surfactants are able to lyse cells and denature proteins.

Figure 1. 3. Schematic of non-covalent binding of CNTs. Upper panel on the right
showed aromatic rings of adduct molecules adhere to the main body of CNTs due to
π-π stacking. Bottom panel on the right showed molecular chains adhere to main
body of CNTs due to van der Waals interaction and hydrophobic interactions.
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1.2.2. Covalent functionalization of carbon nanotubes

Figure 1. 4 Schematic of covalent binding of CNTs [52]. (a) CNTs are oxidized and
then conjugated with hydrophilic polymers; (b) photoinduced addition of azide
compounds with CNTs; (c) Bingel reaction on CNTs; (d) 1,3-dipolar cylcoaddition
on CNTs. Further conjugation of bioactive molecules can be applied based on such
functionalization.
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For covalent binding (Figure 1. 4), the most commonly used functionalization
method to function CNTs is oxidation [60]. In brief, oxidation reagent such as hydrogen
peroxide and nitric acid is used to form carboxyl groups on the terminal or side wall of
CNTs. These oxidized CNTs are further attached to hydrophilic polymers to prevent
aggregation due to charge screening effects. In the community, a couple of different
polymers such as PMMA [61], PEG [62], etc. were successfully attached to oxidized
CNTs. This further conjugation of polymers allows attachment of biological functional
molecules. In our group, we firstly fabricated CNT-PLGA conjugate for the use of gene
delivery in biological system (Chapter 4).
Second route of covalent functionalization of CNTs is cycloaddition. This type
of reactions happens on the sidewall of CNTs. One of the unsaturated bond in aromatic
ring of CNTs is broken and a new cyclic adduct will be added on. There are three major
cycloaddition reactions in functionalization of CNTs. Azides were introduced onto
sidewall of CNTs by photochemistry [63]. Carbene compounds were generated on the
sidewall of CNTs by Bingel reaction [64]. 1, 3-dipolar cycloaddition have also been
used to generate functional groups to the sidewalls of CNTs [65].
These covalent reactions impair the atomic arrangement of carbon and
reorganize electron cloud of CNTs. Therefore, the electron and thermal conductivity and
optical properties are altered. Despite this disadvantage, covalent functionalization could
have the biological cargoes linked to CNTs to be more stable in biological system.
Functionalized CNTs were also be able to maintain temporal drug release profiles (as
shown in Chapter 4).
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1.3.

Cell fate regulation
Tissue formation, function, regeneration after damage and pathology formation

are the result of temporal and spatial organization of individual cell fates [66]. Individual
cell fate is the consequence of the cross talk of cells to its microenvironment and
neighboring cells. In brief, cells sense the physical cues and soluble chemical cues by
the receptors on the cell membrane [67]. These signaling cues are read and translated
into intracellular cues. Then, cells are able to differentiate to the desired lineage. Thus,
we have two options to direct cellular

behavior: (i) construct biomimic

microenvironment which favors desired cellular differentiation; and (ii) deliver key
intracellular cues into cell and control the cell fate.

1.3.1. Extracellular cues to regulate cellular behavior

Figure 1. 5 Schematic of Extracellular matrix regulating cell fate. Cells will sense
physical signals and soluble signals and express genes. The receptors translate
signaling cues through PLC RAS and PI3K to gene expression. The extracellular cues
includes physcial signals, soluble signals and cell-cell interactions. Physical signals
includes fribronectin, fibrillin, vitronectin, collagen, laminin and other stromal
properties. Soluble factors includes growth factors cytokins and outsourced chemical.
Cell-cell interactions includes cadherins and CAM’s.
12

Extracellular environment is the area full of surrounding cells and signaling
molecules [66]. There are three major types of effectors: (1) insoluble signaling
molecules, such as extracellular matrix proteins (ECM): collagen, fibronectin,
vitronectin, elastin, etc.; (2) soluble signaling molecules such as growth factors and
cytokines; and (3) cellular membrane proteins involved in cell-cell contact (Figure 1. 5).
In terms of engineering regenerative tissue by controlling extracellular matrix,
scaffold architecture, fibrils organization, mechanical strength, in combination of surface
topography are key effectors to modulate cell fate [66]. For instance, cellular behavior
was found to be influenced by microenviromental stiffness [66]. Cells were less
migrated due to reduced spreading and disassembling of actin while they are seeding on
a weak gel, cells behaved the opposite on stronger scaffold in contrast [68]. Moreover,
scaffold should be able to withstand cell contractile forces which generated by via cell
and scaffold [69, 70]. On the other hand, cells preferred to proliferate, migrate and
mature on substrate which has similar modulus as their donors. Bone exhibits strong
mechanical properties since it provides structure stability for the body and it allows for
millions of loading cycles throughout a person’s lifetime [71]. However, both natural
and synthetic polymers were low in strength which couldn’t meet the requirement for
bone tissue engineering that bone cement must meet approximate mechanical strength of
where it is replacing, eg. human trebecullar bone’s compressive modulus is 5 to 50 MPa.
Either crosslinking or blending with high stiffness materials should be carried out to
enhance the mechanical strength of polymer substrate for bone tissue engineering. As a
result, high modulus materials are preferred for bone tissue engineering.
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Surface roughness or surface topography is another important property that
allows for osseointegration in scaffolds, as demonstrated by Goldberg group, Feighan
group and D’Lima group [72-74]. Topography would affect cell spreading and cell
activities [75], could significantly increase total surface area as well that cells would
sense and migrate [76]. Additionally, Cells could sense surface grooves which would be
either wide or narrow and in turn cytoskeleton would adjust to it [77]; cells also could
respond to microscale changes of the surface by tuning cell orientation and motility [78].
These micro or nano scale differences could be achieved by fabrication process such as
introducing nano materials into basal materials and using mirco/nano fabrication
techniques. In Chapter 3, creating a scaffold with certain surface roughness is the first
challenge. Then, cells would sense these factors by membrane receptors [67]. These
factors would be transduced into intracellular signals, affecting gene expression through
receptor mediated transduction pathways, such as integrin pathway, mitogen activated
protein kinase pathway, mechano-transduction pathway, etc.. Therefore, to engineer
microenvironment with proper property could lead cells to a desired fate.

1.3.2. Intracellular cues to regulate cellular behavior
Other than physical cues; genes, transcription factor, and signaling molecules can
induce cell differentiation and control cell phenotype as well (Figure 1. 6).
Subsequently, approved clinical gene therapy was started in 1990s [79]. More and more
gene therapies either in experimental or clinical stages have been proved promising in
curing human diseases. However, there is still a challenge that a safe, efficient and longterm delivery system is required [80].
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Figure 1. 6 Schematic of how intracellular cues to regulate cell fate. Genetic materials
and transcriptional factors are delivered into cell and regulate gene expression. In
brief, DNA or RNA conjugates to gene factors firstly, and then the whole conjugate
will bind to membrane receptor. Through endocytosis the whole conjugate will be
absorbed by cell. Thus, DNA or RNA will be released and finally affect gene
expression.
Currently, retrovirus [81], adenovirus [82] and adeno-associate [83] viral vectors
are major types gene vectors widely used due to their ability to infect cells and transfer
target genes. The ideal gene vectors need to fit such requirements that (i) can transduce
genes into specific target cells without infecting normal cells; (ii) can integrated into the
target genome with high efficiency, and (iii) the transcriptional unit should be responded
to the regulatory elements. Through viral vectors (Figure 1. 7) are beneficial in efficient
delivery and transducing cells, there are still concerns which emphasized on that some of
viruses are deadly diseases intriguer, such as human immunodeficiency virus (HIV) and
human T-cell lymphotropic virus (HTLV) (Figure 1. 7). Additionally, some virus may
still trigger immune response and result in lowing efficiency.
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Figure 1. 7 Schematic of vectors used in gene therapy and drug delivery. There are
two major categories: viral vectors and non-viral vectors. Commonly types of viral
vectors are: adeno virus and retro virus, which differs from the genetic materials
incorporated inside (RNA and DNA respectively). Commonly types of non-viral
vectors are liposomes, polymers and dendrimers, which are usually positively
charges in order to facilitate DNT/RNA conjugation.
Consequently, non-viral vectors (Figure 1. 7) are taken into considerations.
Polymers and lipids are most commonly explored materials for drug delivery. Synthetic
polymers such as PEG [84], PLA [85] and PLGA [86]; natural polymers such as
chitosan [87], collagen [88] or gelatin [89] and lipids [90] were used to synthesize
nanoparticles, liposomes and micells. These polymers and lipids can be either
chemically modified or not modified to encapsulated drugs. Liposomes are spheres
contain a separate liquid phase from the element which could protect the genes from
degradation. Drugs are released in a controlled manner due to surface and bulk
degradation or phase transition. However, concerns arise that immune response may
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occur due to heterogeneity of ex-original materials and efficiency is low. Hence, there is
a need to construct a high efficient non-viral vector.

1.4.

Carbon nanotubes in biomedical engineering applications
The unique properties of CNTs lead CNTs more attractive in biological

engineering applications. It is expected to use CNT based biomaterials for clinic use in
the near future. CNTs can be used to design mechanical enhanced scaffold to stimulate
cellular growth. CNT based biomaterials has also been applied into bone, nerves, and
cardiovascular system. There has been progress in the use of CNTs in controlling
cellular alignment, to enhance tissue regeneration, growth factor delivery and gene
delivery.

1.4.1. Carbon nanotubes to controlling cell alignment
As we indicated above, area of cell expansion and topography play important
role in cell survival, differentiation, vascularization and cancer development. A few
studies have already demonstrated that mesenchymal stem cells (MSCs) can be
differentiated into multiple cell line by simply controlling the disorder or the dimension
of nanostructures [91]. The result showed the differentiation found not many differences
in the case where soluble cues were used. Cell polarization induced by alignment could
be an answer to the critical hurdle of tissue engineering: lack of enough vascularization
in the scaffolding materials (200 μm deeper in the scaffolding materials). More
interestingly, take tumorigenic fibroblast as an example, they lay down collagen in an
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aligned fashion, facilitating cell migration and tumor generation. Normal fibroblast only
lay down collagen in a random fashion, forming normal phenotype.
CNTs are nanosized rod-like materials. Despite their fascinating electrical and
thermal conductivity, they can be used to engineering nano topography on 2D substrate
in an aligned manner. Currently, there were several methods have been developed to
align CNTs. Microfluidic flow [92], DC electricity [93], centrifugal forces [94], and
micro patterning [95] were all used to align CNTs on 2D substrate. A variety of cell
lines such as MSCs [96], Chinese hamster ovary cells [97], etc. was successfully aligned
on this 2D substrate. The successful alignment of CNTs on 2D substrate would also
increase the future application of electrical shock and growth factor conjugation for
further induction of either differentiation of stem cells or the maturation of adult cells.
We may also utilize this CNT to study cell polarization and tumor genesis. In our group,
we were trying to develop a CNT based 2D substrate for cellular attachment and
alignment for both adult cells and single human embryonic stem cells (hESCs) (Chapter
2). The further application would have been utilize this substrate for inducing hESC
differentiation at single cell level.

1.4.2. Carbon nanotubes for bone tissue engineering
CNTs have been used to study neurogenesis [98], cancer treatment [99] and
especially in osteogensis [100]. There have been several reports of the influence of
CNTs on osteoblastic cells in vitro, most of these studies indicated that CNT promote
the proliferation and cell growth of osteoblastic cells [34, 101, 102]. This is a valuable
characteristic of CNTs for its application in bone tissue regeneration. Furthermore,
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investigators have shown that CNTs possess compatibility with bone tissues that CNTs
neither increased the inflammation of the bone tissue, nor blockd the bone tissue
regeneration. In contrast, CNTs provided assistance in bone tissue regeneration and
showed integration with the tissue [103]. More interestingly, they could integrate
successfully into bone tissue [8].
Zanello et al. discovered that osteoblasts change morphology and express plate
shape crystals in the presence of CNTs [34]. These osteoblasts which exposed to CNTs
were more differentiated and osteocyte-like as compared to osteoblasts cultured on a
glass surface which exhibit a flat morphology [104]. Plate shaped crystals aggregated in
clusters outside the cells and were similar in shape to hylauic acid found in woven bone
[105]. In another route, Yi et al. found gold nanoparticle coated surface promote
osteogenic differentiation through mitogen-activated protein kinase p38 MAPK
pathway. Osteoblasts sensed gold nanoparticles via integrin receptors and induced p38
kinase activation which upregulated osteogenic differentiation gene expressions [106].
Kim et al. also demonstrated Ti surface roughness enhances osteoblast differentiation
via mediating MAPK pathway. Bone formation genes were expressed by activating
protein kinase A (PKA) due to occupation of integrin receptors [107]. Moreover, studies
have shown genes code BMP-2, osteonectin and osteopotin have been upregulated under
exposure of CNTs [108-110].
As a result, more CNT composites are taken into account for bone tissue
engineering. Abarretegi et al. developed a chitosan/CNT scaffold and evaluate its effect
in tissue engineering. Scaffold performed a satisfactory result of cell adhesion, cell
viability, and cell proliferation on the external surface [111]. Meanwhile, with the
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addition of rhBMP-2, cells were differentiated towards osteogenic lineage. Furthermore,
Mikos et al. fabricated an ultra-short single wall CNT nano composite and evaluated the
effects of mechanical strength, porosity and material composition on bone marrow stem
cells. Results showed CNT materials hold promising potential in bone tissue engineering
with tunable porosity and mechanical strength [112]. Edward et al. developed a
PLGA/CNT electronic spinning nanofibers, not only are cell growth supported, but also
full range of electronic conductivity and mechanical property of CNT are fully utilized
[113]. It has been suggested that CNT is a good type of material for bone regeneration.
Thus, a promising chapter in the study of biological applications of s in bone tissue
engineering has begun (Chapter 3).

1.4.3. Carbon nanotubes for neurogenesis
Another more sophisticated application for using CNTs in tissue engineering is
Neurogenesis [114]. The great electrical conductivity would provide superb environment
for neural progenitor cells to develop axons [115]. Quite a few studies have been
developed to study neurogenesis on CNT based substrate using different cell lines. As
early as in 2000, Mattson et al. provided the fundamental study of neuronal
differentiation of rat embryonic stem cell on pristine CNTs [116]. A few years later, Hu
et al. reported they successfully tested the signal transfer between the synapse of neuron
cells cultured on CNTs based substrate [117, 118]. Other than the neuron cell maturation,
CNTs could also induce differentiation of hESCs to neuron lineage on a 2D substrate
composed of CNTs [119]. It has been demonstrated that CNTs were biocompatible to
neuron cells. Now researchers are more focused on using CNTs to assemble aligned
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networks for neuron network regeneration, which could be potentially a big leap in
neuron regeneration. Overall, there is one extra credit of using CNTs than using micro
patterning: CNTs will not only provide axon growth direction, but also facilitate
electrical signal to transfer along CNTs alignment. These properties in turn help neuron
regeneration.

1.4.4. Carbon nanotubes for drug delivery
CNTs are needle like and very easy to penetrate the cell membrane due to its
high volume to radius ratio. However, CNTs are not suitable for directly transferring
genes in biological system. Subsequently, scientists discovered that functionalized CNTs
have decreased their intrinsic toxicity [120]. The major modifications of CNT are
covalent and non-covalent functionalization [52] as we discussed above. For a quick
reminder, oxidation and cylcoaddition reaction are common methods in covalent
functionalization to add functional group to CNTs’ sidewall or ends [121, 122]. For noncovalent functionalization, CNTs are coating with a layer of molecules by π-π stacking
or the small interactions between the molecules.
On the other hand, as a matter of fact, drug carriers in nano sizes have
advantages in drug delivery systems: (i) protection of delicate drugs, (ii) enhance
absorption in selective tissues, (iii) control drug distribution profile and (iv) enhance
intracellular penetration [123]. But the CNT cellular uptake mechanism may differ
depending on the functionalization and size of the CNTs [124]. CNTs have been used to
efficiently shuttle various biological cargoes, ranging from small drug molecules [125]
to biomacromolecules, such as proteins [126, 127] and DNA [128, 129] and RNA [130],
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into different types of cells via endocytosis [131]. Moreover, small amount of CNTs was
found to be biocompatible to cells.
Carbon based biomaterials is leading a new trend in various medical areas
especially in tissue engineering. Functionalized CNTs based biomaterials which
enhanced its biocompatibility can continuous contact with biological systems and can be
used as scaffold to support the cells and to deliver drugs. Liu Z. et al have successfully
delivered siRNA by phospholipid PEG (PL-PEG) functionalized CNTs into tumor cells
and tissue to inhibit cell proliferation and tumor ingrowth and enhance CXCR4
expressions ex and in vivo [132-134]. siRNA was released by cut off S-S bond attached
to PL-PEG which would not last for a longer period. Therefore, CNT are found to be an
effective gene deliver vesicle but a long term release profile using CNT is still needs to
be investigated.

1.4.5. Carbon nanotubes for disease imaging and detection
Because CNTs hold intrinsic optical properties, CNTs are good candidate for
optical imaging. SCNTs have small band gaps on the order of 1 eV, makes it auto
fluoresce in the near infrared range. The excitation and emission bands of SCNTs are
separated broadly. The background fluorescence can be reduced. Relying on this
properties, a few groups have developed imaging SCNTs within the cell body. Pilot
study using SCNTs for biomedical imaging in vivo was first conducted by Weisman
group. They successfully imaged food bio-distribution in larvae. SCNTs were also
promising in cancer imaging that tumor retains naosized materials by EPR effect.
Researchers reported that functionalized SCNT signals was observed in living mice
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model. The in situ and in vivo imaging utilizes the photoluminescence property of SCNT.
SCNT has an auto fluorescence in the near IR range, allowing real time, in vivo and in
situ imaging in a living organism. Despite that, CNTs could be also used for cancer
imaging by adding receptor target adducts or CNTs itself would be retain in tumor tissue
due to EPR effect [135-140].

1.5.

Toxicity of carbon nanotubes in biomedical engineering application
The toxicity of CNTs has been drawing attention of researchers in biomedical

nanotechnology. As of 2007, preliminary results highlighted the difficulties in
evaluating the toxicity of this heterogeneous material. CNTs have so many parameters
which have considerable impact on the toxicity of CNTs. These parameters includes:
structure, size distribution surface area and chemistry, surface charge, agglomeration
and purity. Interestingly, available data clearly showed that, CNTs could cross
membrane barriers by its own property. Then here comes out a paradox. If raw materials
reach the organs, they can induce harmful effects such as inflammatory and fibrotic
reactions. Thus, functionalization of CNTs are preferred. Overall, CNTs are very
promising in cancer therapy and controlling cell fate internally [141, 142].
More specifically, except the use of CNTs in cancer therapy, toxicity concerns
are always there for either stem cell differentiation or adult cell maturation. In early
years, a number of studies have demonstrated that CNTs could have potential toxicity in
biomedical engineering applications. Others claimed there was no toxicity at all. These
findings are complicated and paradox. Recently, many comprehensive studies revealed
convincing data about CNT toxicity. CNTs retain intrinsic toxicity due to that their
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inherent properties: super hydrophobicity and high surface area. For example, Ding et al.
discovered that CNT increases apoptosis of human skin fibroblast [143]. In addition, the
HEK 293 cell proliferation was found to be inhibited by co-culture with CNTs. Note,
CNTs used in these studies were not functionalized. Liu et al. tested the cytotoxicity of
oxidized CNTs; they found that differentiation and proliferation of MSCs were inhibited
by oxides CNTs [144]. Not only MSCs, lymphocytes were also has been induced
apoptosis after exposure of CNTs [145]. Since simple oxidization didn’t show promising
in cytotoxicity, researchers then moved to decrease the toxicity by decreasing the
intrinsic hydrophobicity of CNTs. PEGylated CNTs showed minimum toxicity in vitro
studies. Several other reports has demonstrated the polymer functionalized CNT are not
toxic to a variety of cell lines at all.
CNTs are not going to be used only for in vitro studies. To address more clearly
for the side effect of CNTs in human body, researchers use animal models as references.
There were a few studies discovered pristine CNTs definitely do damages to pulmonary
system, suggesting aerosol exposure of CNTs needs to be avoided. Some further study
demonstrated that the toxicity of the CNTs could have been size dependent. The toxicity
of CNTs with smaller size in nanometer scale was significantly different from the CNTs
with larger size in micrometer scale [146]. Then, more research focused on
functionalized CNTs were accumulated in spleen and liver. However, little toxicity has
been observed by using functionalized CNTs. Because of the successful minimization of
toxicity by functionalization, the bio-distribution of functionalized CNTs was studied.
Interestingly, the functionalized CNTs were able to be cleared by urea within hours. No
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uptake or accumulation was found in organs such as liver and spleen by radioactive
labeling.

1.6.

Summary
CNTs for biomedical engineering has been an emerging area due to the special

and fascinating physical and chemical properties CNTs hold. Although a few conclusion
drew from some groups may be paradox, CNTs are promising candidate in tissue
engineering, biomedical imaging and gene delivery. However, more research attention
should be focused on basic chemistry of CNTs functionalization and basic biology of
degradation, distribution and clearance of CNTs in human body. In the following three
chapters, we demonstrated the ability of CNTs as extracellular and intracellular
regulators to control cellular behaviors.
As extracellular matrix, we developed an aligned CNT substrate to align
HUVEC and culture hESCs at single cell level (Chapter2). It is well acknowledged that
culturing single hESCs is extremely difficult. By either mechanical or enzymatic
breakdown of hESC colony, it is able to culture single hESCs. However, these single
cells still tend to migrate to crowd together. With our newly developed CNT substrate,
we could culture hESCs at single cell level, and could control their migrating as well.
This is the great novelty in the Chapter 2. By culturing single hESC, we could take a
step forward to differentiate single hESCs to desired phenotype with limited
heterogeneity.
We also developed a CNT containing PLGA scaffolds for bone regeneration in
Chapter 3. Previous study has showed that CNT addition increased either stiffness or
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surface roughness, which in turn increased osterogeneis. The great novelty in Chapter 3
lies in that by developing a 3D CNT content scaffolds, we were able to coupling the
surface roughness and mechanical strength to osteogenesis. As we confirmed, the
increase of nano roughness and mechanical strength together helped improve
osteogensis.
As intracellular cue vesicles, a number of biological cargo has been already
delivered intracellularly by a several types of linkers such as PEG or not. We developed
a new CNT-PLGA conjugate to delivery biological cargoes into cells in Chapter 4. The
innovative aspect of our DDS system based on CNT-PLGA is that we can tune temporal
release profile by controlling the molecular weight and PGA to PLA ratio.
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CHAPTER 2
Alignment of Carbon Nanotubes: An Approach to Modulate Cell Orientation and
Asymmetry
2.1.

Introduction
Stem cells are promising in tissue engineering, as their differentiated derivatives

can be used to reconstruct most biological tissues. These approaches heavily rely on
biophysical cues that tune the ultimate fate of stem cell and provide by cellular
microenvironment [147]. Particularly, topography plays a crucial role in affecting cell
behavior such as spreading, migration, and differentiation among other characteristics
[148-150]. Focal adhesion is a key component by which cells are able to adhere to
substrates. As cells bind to extracellular matrix (ECM) ligands, integrins are clustered
and therefore form focal adhesion. Cells sense topographical structure through focal
adhesion, therefore control cellular alignment and other cell behaviors [149]. Cellular
alignment is crucial for the function of certain tissues in the human body. For instance,
the mechanical strength of bone depends heavily on the cytoskeletal alignment of
osteoblasts [151]. This allows us for engineering a unique topographical substrate, which
enables integrin to attach in a controlled manner therefore affect the cell behavior and
ultimately tissue function.
However, the mechanism for the change of cell behavior induced by cell
alignment remains somewhat elusive. Mechanotransduction signaling pathways are
generally hypothesized with tension forces being transmitted from focal adhesions
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through the cytoskeleton and ultimately to the cell nucleus [152, 153]. These forces are
mediated by trans-membrane adhesion proteins and can therefore affect the expression of
signaling proteins [154-156]. For instance, collagen type I is a ligand for integrins that are
bound to integrin linked kinase. Integrin linked kinase activation has been reported to
increase cytoplasmic levels of β-catenin, which positively affects the Wnt-β catenin
signaling pathway. This signaling cascade can potentially result in the neurogenic
differentiation of embryonic stem cells [154-157]. Additionally, nuclear shape changes
via connections between the cytoskeleton and the nuclear matrix [158].
Nano and micro engineered topographies are of current interest to develop
cellular alignment [159]. Stem cells were differentiated into a neuronal lineage with
significant neurite extensions confined in the nanogrooves [159] or along with direction
of electronic spun fibers [160]. The differentiation of exoderm or endoderm can be
determined via controlling the colony size of embryonic stem cells by micropatterning
technology [161]. These studies mostly focus on a view of how cellullar alignment is
affected by the microscale substrate. Few reports have focused on the alignment of cells
induced by nanoparticles. Thus, we are interested in using CNTs to engineer nano
topographies.
CNTs have become an attractive option to biological applications for their unique
characteristics [162, 163]. CNTs have been used as a developing platform to enhance
nano roughness [19] among other applications [164-166]. Specifically, it has been
confirmed statistically that CNTs were able to increase the number of focal adhesions and
expression of vinculins [167]. Rigid dash like and dot like focal adhesion structures have
also been monitored on CNT substrates [168]. Our previous study also demonstrated
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increased number of cell attachment by addition of CNTs [169]. Recently, Namgung et
al. successfully aligned human mesenchymal stem cell on CNT coated surface using a
spin coating procedure [96]. These findings inspire us to tune cellular alignment through
focal adhesion sites by regulating CNT substrates.
With these in mind, our goal is to develop a platform coating aligned ligand
functionalized CNTs to provide attachment sites, which cells can decipher and bind to.
Our hypothesis underlies that cells will be able to recognize and adhere only to those
CNT patterns, such that cytoskeleton will organize to adopt the aligned fashion through
focal adhesions.
To achieve the goal, we functionalized carboxyl CNTs with the ligand proteins
and aligned these CNT-ligand conjugates on an Au coated glass substrate by spin coating.
We characterize the CNT-ligand and the surface properties of substrate by various
techniques. In addition, we used human embryonic stem cells (hESC) and human
umbilical vein endothelial cells (HUVEC) as model cells in order to demonstrate the
spreading and cytoskeleton organization on the substrate. The uniqueness of this paper
lies in the ability of these patterns to control cell attachment and shape through the
tenability of density and dispersion of these CNT-ligand conjugates.
By developing this aligned CNT pattern, we were able to tune single hESC
attachment and alignment of HUVEC. We have provided a new approach to tune hESC
culture at single cell level. This would allow us for better understanding differentiation of
hESC at single cell level. Most importantly, the differentiation of hESCs could be
conducted at single cell level by using this CNT pattern. Potentially heterogeneity could
avoid in hESC differentiation.
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2.2.

Materials and methods

2.2.1. Substrate preparation
Coverslips were rinsed in sterilized water for 5 min, dried with lab provide air
blow for 5 min, and cleaned with an ozone cleaner (BioForce Nanoscience) for 3 min.
Coverslips were then coated with a first layer of 5 nm Ti and second layer of 10 nm Au
through sputter coating (Denton Desk II Turbo Sputter Coater and Denton Desk II
Sputter Coater respectively). For Ti coating, a vacuum at 10 Torr has been applied to the
chamber with Ar gas blowing into the chamber. 15 seconds of sputter coating time was
applied. For Au coating, a vacuum at 100 Torr has been applied with Ar air blowing into
the vacuum chamber. 30 seconds of sputter coating time was applied. All Au coated
samples were stored in petri dish sealed with parafilm till use to prevent dust.
Total of 100 µg of carboxyl CNTs (Nano Lab, purity>95%) were dispersed in 0.5
ml of 0.2 mol/ml 2-(N-Morpholino)ethanesulfonic acid (pH 5.6) (MES, Acros) buffer
under sonication for 1 hour at room temperature. 0.25 ml of 0.8 mol/ml 1-(3Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC, Acros) and 0.25 ml of
0.4 mol/ml N-Hydroxysuccinimide (NHS) (Acros) in MES solution were added to
activate carboxyl groups [170, 171]. The mixture was washed with PBS and centrifuged
in a MW 100 KDa cutoff centrifugal filter (Millipore) (4 ml) to remove EDC and NHS at
5000 g three times for 30 minutes each. Refill 4ml of PBS in centrifugal filter tube each
time. Then, 5 µg of a model protein was added at 4 oC and incubated overnight. Finally,
the mixture was washed and centrifuged in a filter to remove un-conjugated protein at
5000 g six times for 30 minutes each [171]. Refill 4 ml of PBS and sonicated for 10 mins
to resuspend mixture before each following centrifuge. The final CNT-protein in PBS
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solution (resuspend in 1 ml PBS) was collected and stored at -20 oC until use. These
studies used Matrigel (Invitrogen), bovine serum albumin (BSA) (Sigma) and fluorescent
BSA (fBSA) (Sigma) as model proteins for characterization of adhesion to CNTs.
Fibronectin (Sigma) and Matrigel were used to provide cell attachment for human
umbilical vein endothelial cells (HUVECs) and human embryonic stem cells (hESCs),
respectively. The prepared CNT-ligand conjugations were stored in -20 oC until use.
In order to obtain the aligned CNT pattern on the surface, substrates were rinsed
in CNT-ligand solution for 12 hours. Then CNT-ligand conjugates were aligned on the
Au coated substrate through spin coating (Chemat Technology). The solution was spun at
800 rpm for 10 seconds and 5000 rpm for 1 minute. After incubation in ambient
conditions in a petri dish sealed with parafilm for 30 minutes, aligned CNT substrates
were gently washed with PBS and ethanol twice to remove any unseated CNT-ligand and
remaining particles. Poly(ethylene) glycol (PEG) thiol (Sigma) is placed in ethanol
solution (1 µl/ml) and coated onto the CNT-ligand substrate for 10 minutes to passivize
rest of Au coated area and prevent non-specific cell attachment.

2.2.2. Substrate characterization
For transmission electron microscope (TEM) characterization, several droplets of
homogenized carboxyl CNTs and Geltrex conjugated CNTs solution were coated onto
200 mesh copper grids and dried at room temperature for 10 minutes. TEM images of
carboxyl CNTs and Geltrex conjugated CNTs were visualized by a Hitachi H-8000 TEM
system.
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For scanning electron microscope (SEM) characterization, prepared substrates
with carboxyl CNTs were imaged with a Zeiss Ultra Plus SEM system. We use carboxyl
CNTs instead of CNT-ligand conjugates due to the consideration of conductivity.
Immunofluorescent images were captured with fBSA conjugated CNTs on
substrates and imaged by a Nikon Eclipse 80i microscope.
UV-Vis Spectrum characterization was done with 5 g/mL BSA solution and 5
g/mL carboxyl CNT homogenized solution prepared by sonication (30 mins). 5 g/mL
BSA conjugated CNT solution was prepared with 1 hour incubation of 5 g/mL BSA and
5 g/mL carboxyl CNTs at 37oC followed by 1 hour incubation at room temperature. The
unconjugated BSA was then removed with a 100K molecular weight cutoff centrifugal
filter (Millipore) at 5000 g for 30 min for 6 times. The UV-vis spectrum was recorded
using a Beckman Coulter DU 730 UV-Vis spectrometer with a step of 1 nm.

2.2.3. Cell Culture
Human umbilical vein endothelial cells (HUVECs) (Lonza) at passages 8-12 were
used for this study. Cells were seeded on CNT aligned substrates at a density of 5,000
cells/cm2 in Ham’s F12K medium (Invitrogen) supplemented with 2 mmol/L glutamine
(Invitrogen), 1.5 g/L sodium bicarbonate (Sigma), 0.1 mg/mL heparin (Fisher), 0.03-0.05
mg/mL endothelial cell growth supplement (BD Biosciences), 10% FBS (Invitrogen) and
1% penicillin-streptomycin (Invitrogen). Medium were changed every 3 days, HUVECs
were passaged every 7 days.
hESC line H9 was purchased from WiCell with cell lines grown on a mouse
embryonic fibroblast (MEF) (CF-1, Millipore) feeder layer in DMEM/F12 (Invitrogen)
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with 20% KnockOut Serum (Invitrogen), 0.1 mM MEM Non-Essential Amino Acids
(Invitrogen), 3.5 mM L-Glutamine final concentration (Invitrogen), 100 µm 2Mercaptoethanol (Sigma) and supplemented with 10 ng/ml human recombinant bFGF
(PeproTech) as shown in WiCell protocols. Medium was changed daily and cells were
passaged on every fifth day of culture with collagenase type IV (Invitrogen).
MEF were grown in DMEM (Invitrogen) with 10% FBS (Invitrogen) and
100U/100µg/ml of penicillin/streptomycin (Invitrogen). Medium were changed every 3
days. MEF cells were passaged every 7 days. The passages 6 of MEF were used as feeder
layer.
hPSC monolayer culture with single cell passaging was established as described
[172]. Briefly, hPSC were switched from feeder-dependent culture to feeder-free
conditions with 20 gauge sterile steel tips. hPSCs were grown as colonies for 2-3
passages on growth factor reduced Geltrex (Invitrogen) coated 6-well plates (BD
Biosciences) in MEF conditioned medium supplemented with 10 ng/ml bFGF. Cells were
passaged mechanically on day five.
Conditioned medium was prepared as described, mitotically inactivated MEF
through Mitomycin C (Sigma) treatment at 10 µg/ml for 2.5 hours were plated on
gelatinized flasks (Sigma) at a density of 60,000cells/cm2, the following day cells were
washed with PBS (Sigma), medium was changed to hESC medium without bFGF
addition at 0.5ml/cm2 and collected every 24 hours for 7 days.
Before cell culture the conditioned medium was filtered and supplemented with
10 ng/ml bFGF. On the following passage, hPSC colonies were treated with TrypLE
Select (Invitrogen) for 1 minute, gently dissociated to single cells and plated to new wells
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at approximately 80-100,000 cells/cm2. Cells were grown under the same culture
conditions and single cell passaged upon reaching confluence. After stabilization of the
cell culture cells were routinely passaged as single cells on each fourth day with a
seeding density of 50,000 cells/cm2.

2.2.4. Immunochemistry
HUVEC and hPSC single cells were allowed 2-4 hours for attachment to CNTs
and fixed with formalin (Sigma) for 15 mins at room temperature, permeabilized in 0.1%
Triton X-100 (Sigma) at 4 oC for 10 mins, and blocked in 4% goat serum solution at
room temperature for 30 minutes. HUVECs were stained primarily for PECAM-1 at a
1:500 dilution ratio (Cell Signaling) for 60 mins. PSC single cells were stained primarily
for Oct4 at a 1:500 dilution (Santa Cruz Technology) or vinculin at a 1:100 dilution
(Sigma) for 60 mins. Secondary antibodies were purchased from Invitrogen and used at a
1:100 dilution for 60 mins. Rhodamine phalloidin at a 1:100 dilution (Invitrogen) was
used to visualize cytoskeleton structure of HUVECs and hESCs (20 mins incubation).
DAPI (Sigma) was used to visualize nuclei (1:40).

2.3.

Results and Discussion

2.3.1. Preparation and Characterization of Aligned CNT Substrate
As shown in Figure 2. 1, Au coated coverslips were rinsed in a homogenized
CNT-ligand solution. CNT-ligand conjugates would be able to stick to Au coating due to
electrostatic interactions. Then, centrifugal force was applied by spin coating. The CNTligand conjugates would adopt the centrifugal force and would be organized into an
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aligned fashion over the substrate. The concentration of conjugates, rinse time, and spin
coating procedure were adjusted to achieve an ideal performance of CNT-ligand
conjugates on the surface for cell attachment. To prevent non-specific binding of cells to
the non CNT-ligand area, the area with no CNT-ligand conjugates was passivized in
PEG-SH solution at determined concentration. At last, cells were able to attach to CNTligand particles only.

Figure 2. 1 Schematic diagram showing experimental procedure for CNT substrate.
In brief, carboxyl CNTs were functionalized with protein ligand and CNT-ligand
conjugates were aligned on Au surface by spin coating. Then Au surfaces without
CNTs were rendered non-adhesive by thiolated polyethylene glycol (PEG-SH) and
cells were cultured on the substrates.
Multiwall carboxyl CNTs were commercially purchased from Nanolab and
characterized through TEM. As shown in Figure 2. 2A, the length of the carboxyl CNTs
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used in this study is approximately 5 m with the diameter shown in Figure 2. 2B of
approximately 20 nm. These specifications were larger than the single wall CNTs,
facilitating more ligand conjugate to each single MCNT. Consequently, the density of
conjugated protein per CNT will be higher than SCNT. This was a desired property
which facilitates cell adhesion and migration [173, 174]. As we mentioned above in
Chapter 1, toxicity concerns of CNTs in biomedical engineering would need
functionalization of CNTs. Although using CNT as extracellular cues in vitro would
significantly reduce the toxicity concerns of CNTs, there is still critical hurdle that CNTs
need appropriate functionalization to desired application: provide cell attachment sites.
There are two major types of functionalization including covalent and non-covalent
reactions [52]. To achieve covalent binding, reactive groups [175, 176] are formulated to
allow for further attachment of polymer [177], protein [178], and DNA [179]. In contrast,
non-covalent binding is based on π-π stacking between CNTs and aromatic groups from
the linkers [180]. Both functionalization would provide certain degree of protein
attachment. However, there were reports suggesting non-covalent bound biological stuff
may not remain stable in serum containing situations [181]. Thus, based on our goal to
provide cell attachment sites on CNTs, we functionalized CNTs through covalent
reactions that directly link protein ligand to CNTs.
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Figure 2. 2 Characterization of CNT-ligand conjugates and aligned CNT substrate. A.
TEM of carboxyl CNTs. Carboxyl CNT is about 5 µm in length and 20 nm in diameter.
B. TEM image of Geltrex conjugated CNTs. There were several protein particles attached
to the CNTs’ sidewall as squared. C. Fluorescent image of CNT-fBSA conjugation on Au
substrate. Green shows the positive signal of CNT-fBSA on substrate. D. UV-vis
spectrum of CNT, BSA and CNT-BSA conjugates. CNT-protein conjugates and its
dispersion confirmed on Au surfaces which allow cell attachment for HUVEC and
hESCs. E. Low-magnification SEM image of aligned CNT substrate. F. Highmagnification SEM image of aligned CNT substrate. Cleary we’ve seen CNTs were in an
aligned fashion.
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We were able to show highly specific protein conjugation to CNTs for cell
attachment as shown in Figure 2. 2B. This high magnification TEM image showed
Geltrex protein conjugated to CNTs with protrusions from the sidewall of these CNTs to
the space. The sizes of these protrusions were found to be approximately 2 nm, which
correlated with the calculated size of the proteins comprised in Geltrex according to the
3MW 1

equation r = (4πρN )3 [182]. Where MW is the molecular weight of the protein, NA is
A

Avogadro constant. ρ is the density of the solution. Note, the molecular weight for
common extracellular matrix is under 10-100 KDa range, resulted the diameter around 2
nm. fBSA was used as another sample protein for demonstration as shown in Figure 2.
2C through microscopy. CNT-fBSA were shown positively signals on the 2D substrate.
We saw green fluorescence emitted from rod like CNTs, which is generated from fBSA
excited by 488 nm laser. This confirms protein conjugation to CNTs on substrate,
demonstrating the ability of CNT-ligand to provide cell attachment site on substrate. UVVis absorption was also used to test the conjugation spectrometrically. As shown in
Figure 2. 2D, CNT-BSA conjugates exhibited an enhanced absorption at 280 nm, which
was the typical absorption of a protein. This type of UV absorption was similar to other
studies of analyzing proteins [183]. With all these in mind, we confirmed the ability of a
fibronectin or Geltrex protein could be conjugated to CNTs covalently. Therefore, the
CNT-ligand conjugates would provide enough attachment sites for cell adhesion.
Recent studies have also shown that aligned topographies were highly effective in
directing cell differentiation and adopting specific cell behavior [154, 184-189]. Besides
dip pen nanolithography [190], UV lithography [191] and electro-spin nanofibers [191,
192], we were able to align CNT-ligand conjugates on Au coated coverslip. As observed
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in low-magnification SEM images (Figure 2. 2E), the rod shaped tubes representing
carboxyl CNTs were well aligned in the direction of centrifugal force. In the high
magnification SEM image of Figure 2. 2F, carboxyl CNTs with different lengths were
clearly shown in an aligned fashion throughout the substrate. Our results correlated well
with previously report, which aligned single wall CNTs on a poly-l-lysine substrate by
spin coating [193, 194]. Through the parameters listed in this paper, we have successfully
developed a highly aligned multiwall carboxyl CNT substrate for its utility in cell culture
systems.

2.3.2. Adhesion of HUVEC and hESC single cell on Aligned CNT Substrate
Cellular adhesion to the matrix is a key contributor to many cell functions
including proliferation and apoptosis. Significant interest has been directed into how
factors such as the topographical and mechanical cues presented in cell adhesion affect
cellular behavior. These microenvironments have been shown to control cell spreading,
migration, and differentiation among other characteristics. A combination of matrix
factors such as topography, mechanics, and ligand density have all been implicated in the
direction of cell behavior and fate [155, 174, 195]. However, these factors and interplay
between factors remain poorly understood and have been identified as a crucial portion to
cellular function.
These microenvironment also play a crucial role in cell shape, which in turn also
can affect cell behavior [148-150]. Stem cells are particularly interesting to observe cell
shape because of the capability of differentiating into the many cell types in the body and
contain significant potential for use in regenerative medicine and tissue engineering [159,
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196, 197]. It is understood that mechanical and topographical cues from the hESC’s
immediate environment can affect its cell shape and therefore differentiation lineage in
addition to the more studied soluble factors [66, 147, 196]. Nano-engineered
topographies are of current interest because they are able to avoid the use of biochemical
factors, which are both expensive and difficult to control in terms of concentration [159].
Cellular alignment is crucial for the function of certain tissues in the human body, for
instance, the mechanical strength of bone structures depends heavily on the cytoskeletal
alignment of osteoblasts and their surrounding collagen matrix [151]. hESC
differentiation can be induced by physically aligning the cells in a uniaxial manner.
hESCs have also been shown capable of differentiation along osteogenic and neurogenic
lineages when cultured on nanoengineered substrates [159, 197].
Cellular alignment is highly important in bodily tissues, especially endothelial
cells. The effects of shear stress and nanotopography on human umbilical vein
endothelial cell (HUVEC) alignment have been studied extensively. HUVECs exposed to
1.5 Pa shear stress demonstrated actin filament alignment after 16 hours of exposure28.
Combined effects of micropatterned surfaces and fluid shear stress on the alignment of
human endothelial cells were studied by Vartanian et al [198]. Nano-fibrous structures
have also been considered as an alignment tool. Human corneal endothelial cells are
another cell type that is able to align along the length of Type-I collagen fibrils mediated
by integrins α2 and β1 [199]. CNTs are another highly sought after option for alignment
of cells such as aligning cells for growth and differentiation [200].
Focal adhesions formation is a key component to which cells are able to adhere to
flat substrates. As cells bind to ECM ligands integrins are clustered and focal adhesions
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are able to form while the cell undergoes spreading. Ryoo et al. has statistically
confirmed that CNTs were able to increase the number of focal adhesions per cell of
NIH3T3 cells as well as the expression of vinculin [167]. Zhang et al. also observed dash
like and dot like focal adhesion structures on CNT substrates [168]. Cells sense microenvironmental signals through focal adhesion, controlling cell shape and function by
integrating physical cues [149]. These findings inspire us to tune focal adhesion sites by
regulating CNTs patterns. With these principles and properties of CNTs in mind, this
work establishes a platform which contains aligned CNTs to provide attachment sites to
which cells can decipher and bind. Cells will then be able to adhere migrate in an aligned
fashion on these CNT patterns. The uniqueness of this paper lies in the ability of these
patterns to be used in a wide variety of cellular, particularly hESC, applications to
promote attachment, migration, and differentiation of cells through the tunability of these
CNTs.
Endothelial cells are highly sensitive to shear stress with the ability to be easily
oriented [201] as well as the ability to control orientation and migration of endothelial
cells by distinct fluid flows [202, 203]. Independent to fluid flow, reports show the use of
localized α4 integrin phosphorylation to align endothelial cells [204], while others have
discovered laminin gradients affect endothelial alignment to a high degree as well [205].
Collagen based nanofibers [206] and topographic cues [207] have also induced migration
and orientation of endothelial cells without the use of fluid flow which have lead us to
use aligned CNTs to orient endothelial cells for a variety of applications. With the CNT
fabricated substrates shown here, our results coincide with previous studies in showing
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alignment and migration and to this end, we believe this CNT based substrate can be used
to tune cell growth and migration in a controlled manner.

Figure 2. 3 Immunofluorescent images of HUVECs on CNT substrates. DAPI (blue),
PECAM (green), F-actin (red) are shown. HUVECs are randomly distributed on CNT
randomly assembled substrate, either confined by CNTs or spread over CNTs.
Cell adhesion of HUVEC was performed on both randomly assembled CNT
substrate (Figure 2. 3) and aligned CNT substrate (Figure 2. 4). HUVEC were not in an
aligned fashion on randomly assembled CNT substrate. HUVEC organized cytoskeleton
in random orientations and was confined in a small adhesive area. PECAM-1 staining
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showed a significant lack of cell-cell contact junction indicating cells have limited
mobility on randomly assembly CNT substrate [208]. Consequently, HUVEC cells were
able to sense and recognize CNT-ligand conjugates on substrates ash showed in Figure 2.
3.

Figure 2. 4 Immunofluorescent images of HUVECs on substrates. DAPI (blue),
PECAM (green), F-actin (red) are stained. HUVECs are able to bind to aligned CNTligand conjugates and show a spread, aligned phenotype along CNTs aligning
direction.
In contrast, HUVEC behaves an aligned fashion on aligned CNT substrate. As
shown in Figure 2. 4, immunofluorescent images of HUVECs on aligned CNT substrate
showed that HUVEC cells adapt to the CNT alignment. PECAM-1 staining showed
HUVEC cells had distinct cell-cell contact junctions along with aligned CNT direction.
Cytoskeletal organization was highly stressed towards aligned CNT direction as well.
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Note that HUVEC cells were able to migrate and orientated on collagen based nanofibres
[206] and aligned topography [207], our aligned CNT substrate could provide potential
capability of controlling vascularization and directing stem cell differentiation to those
cells which have specific alignment characteristics, e.g. cardiomyocytes and neurons.
Traditionally maintaining hESC cultures in vitro requires MEF feeder layers and
manual passaging of individual colonies. This method does not lend themselves to large
scale production of pluripotent cells for high throughput experiments. Enzymatic
dissociation of pluripotent stem cells has recently been reported as a method to higher
scale passaging of pluripotent cells for future clinical possibilities [209-211]. However,
problems occurred with enzymatic passaging of hESCs. It is hard to maintain hESCs
within certain size [210, 212, 213]. There is also the possibility of genetic and epigenetic
changes in hESCs [214-216]. Overcoming these obstacles is harnessing hESC research to
decipher single cell level interactions. With a homogenous population of hESC single
cells, it will be feasible to study cell-substrate interactions in greater depth than
previously. Thus, we are trying to use CNT substrate to bring us closer to decipher hESCsubstrate interactions within highly tunable CNT substrate.
Fluorescent images of single hESC were showed in Figure 2. 5. hESC adhesion
experiments were also demonstrated the utility of aligned CNT substrate to be related to
stem cells research. We studied cell adhesion of H9 cell at single cell culture level to
demonstrate the ability to selectively bind to a CNT-ligand conjugates and retain initial
pluripotency. This was preferential over colonies due to the ability to expand hESCs as a
homogeneous population in contrast to cells grown in colonies [217, 218].
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Figure 2. 5 Fluorescent images of single hESC on CNT substrate. A. Top left
showing bright field image of single H9 cell line, top right showing vinculin in green
and DAPI in blue, bottom left showing actin in red and DAPI in blue, bottom right
showing merged image. This demonstrates H9 cells are able to bind to CNT
substrate with normal focal adhesion structure and spreading tendencies. B. Top left
showing bright field image of single H9 cell line, top right showing Oct4 in green
and DAPI in blue, bottom left showing actin in red and DAPI in blue, bottom right
showing merged image. H9 cells are able to attach and spread on CNT substrate
while retaining initial pluripotency.
Single cells were able to bind to CNT substrate with a small percentage of cells
being able to fully spread. To test whether CNT substrate affect initial hESC properties
such as pluripotency, cytoskeletal formation, or spreading tendencies of single ESCs,
markers for Oct4 and F-actin were labeled with antibodies. As shown in Figure 2. 5,
cells retained pluripotency by expressing markers of Oct4 and flattened cell morphology.
As shown with phase contrast in Figure 2. 5, these cells exhibited a more irregular outline
showing more prominent filapodia extensions to surrounding CNT-ligand conjugates.
Focal adhesions were shown to be normal and intact indicating a normal cell phenotype

45

on the CNTs as shown in Figure 2. 5A. This shows the function of the CNT substrate and
the ability to parse the substrate-hESC interaction in future studies.

2.4.

Conclusion
In summary, we have fabricated a substrate patterned with aligned CNT-ligand

conjugates to be used in a variety of potential applications. We test the utility of HUVEC
cells and hESC single cells to recognize, attach and bind to CNT-ligand conjugates with
normal phenotype and function. We found that (A) CNT substrate was able to provide
focal adhesion binding sites for cell adhesion. (B) Through aligning CNT-ligand
conjugates, we are able to align cells in unique direction. (C) This study provides
foundation in specific lineage directing of hESC single cells.
We have provided a new approach to tune hESC culture at single cell level. This
would allow us to culture and induce cell differentiation of single hESCs for a better
understanding differentiation of hESC at single cell level.
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CHAPTER 3

Carbon Nanotube-Poly(lactide-co-glycolide) Composite Scaffolds for Bone Tissue
Engineering Applications

3.1.

Introduction
Bone has the inherent ability to repair small fractures; however, larger bone

defects resulting from trauma, tumor resection or muscuoloskeletal diseases heal over a
long period of time. Orthopaedic surgeons currently employ two approaches to treat bone
defects: (i) autografts, in which the patient’s own healthy bone tissue is used, and (ii)
allogenic grafts, in which bone tissue is obtained from another donor. Autografts are
presently considered to be the best treatment option for their osteoconductivity,
osteinductivity and osteogenecity [219, 220]. However, the use of autografts is restricted
by the shortage of supply and need for a secondary surgery. The use of allografts also
faces major hurdles including the risk of immune response and disease transmission.[221224] In addition, long-term storage of allografts renders the bone structurally weak and
destroys most of the osteoprogenitor cells. In recent years, tissue engineering (Figure 3. 1)
has been evolving as an alternative strategy to develop bone grafts. This approach relies
on the use of combinations of specific cell types, growth factors and three dimensional
(3D) porous scaffolds [225-227].
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Figure 3. 1 Schematic of tissue engineering. In brief, cells are isolated to expand in
in vitro culture. Next, scaffold with growth factor are recruited to regenerated tissue
in vitro. Then, the regenerated tissue is transplanted into human body to replace the
failure tissue. Finally with the successful implantation of regenerative tissue, the
tissue failure could be cured.
A main focus in musculoskeletal tissue engineering is the design of 3D scaffolds,
which guide the intricate dynamic cell signaling processes that governing the migration
of host cells, differentiation of transplanted cells and formation of bone extracellular
matrix (ECM) [228]. In this context, significant effort has gone to fine tune the nano-
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scale structure and chemistry as well as the mechanical properties of scaffolds in order to
recapitulate the in vivo natural bone development.
One important obstacle in construction of engineered tissues is the proper
perfusion of nutrients and oxygen through scaffolds. To overcome this limitation, highly
porous scaffolds, through which nutrients can diffuse, are often preferred. However,
higher porosity may compromise the mechanical properties of scaffolds. Towards
optimizing scaffold properties, there is a need to establish the correlation between
structural parameters (eg. pore size and porosity) and mechanical parameters (eg.
compressive modulus and strength). Bone exhibits strong mechanical properties as it
provides structure stability for the body and it allows for millions of loading cycles
throughout a person’s lifetime. The compressive modulus of an adult trabecular bone is
over 150 MPa; thus, high modulus materials are suitable for bone tissue engineering
applications. Polymers such as poly(lactic acid) (PLA), poly(glycolic acid) (PGA), their
copolymers poly(lactic acid-glycolic acid) (PLGA) as well as ceramics such as HA have
been used to develop 3D scaffolds using various fabrication methods [229-238]. Because
of their biocompatibility, osteoconductivity, and appropriate range of mechanical
properties, these materials have received substantial attention for skeletal repair and
regeneration.
Surface roughness is another important property that allows for osseointegration
of scaffolds [72-74]. In general, cells can sense surface topography and adjust their shape
and cytoskeletal organization accordingly [77, 78]. In the context of bone tissue
engineering, reports have demonstrated osteoblasts to preferentially adhere to substrates
with nano-grooves, as compared to substrates with a smooth surface [239, 240]. As an
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example, Khang et al. showed that the nano and submicron structured Ti surface
upregulates the expression of osteogenic differentiation markers. Interestingly, peaks of
2-4 nm in height induced reorganization of cell cytoskeleton, increased cell spreading and
subsequently enhanced osteogenic differentiation [241]. These studies, all together,
demonstrate the importance of tuning scaffold surface roughness for desired tissue
engineering applications.
We developed an approach to incorporate CNTs into a PLGA scaffold. We
hypothesized that CNTs will increase the mechanical strength of scaffolds and allow for
tuning the surface roughness, which in turn increases the osteogenic differentiation and
bone mineralization. This hypothesis is based on previously published reports
demonstrating the potential of CNTs to (i) reinforce mechanical strength of
composites[8], (ii) accelerate the proliferation of cells, and (iii) create nano-scale rough
substrates leading to improved cell function [34, 101, 242]. To this end, we examined the
effects of homogenously dispersed CNT density on the structural and mechanical
properties of composite CNT/PLGA scaffolds. This was followed by an in vitro
evaluation of MC3T3-E1 osteoblast-like cell proliferation, cytoskeletal organization and
bone mineral deposition on composite CNT/PLGA scaffolds. The innovative aspects of
this project include: (i) the development of a scalable method based on the use of CNTs
to fine tune the nano-roughness of 3D scaffolds, (ii) the establishment of a fundamental
relationship between the CNTs concentration, homogenous/heterogeneous dispersion,
degree of aggregation, and mechanical strength in a PLGA polymeric composite system,
and (iii) introduction of CNT/PLGA composite scaffolds as an osteogenic matrix for
bone repair.
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We have demonstrated the ability of CNT containing PLGA scaffolds for bone
regeneration in this chapter. To the best of our knowledge, previous study has showed
that for CNT addition increases either stiffness or surface roughness, which in turn
increases osterogeneis. The great innovative aspect in Chapter 3 lies in that by developing
a 3D CNT content scaffolds, we were able to coupling the surface roughness and
mechanical strength together to enhanced osteogenesis. As we confirmed, the increase of
nano roughness and mechanical strength together help improve osteogensis.

3.2.

Materials and methods

3.2.1. Synthesis of carbon nanotubes embedded PLGA scaffolds
The fabrication process was showed Figure 3. 2. CNTs were obtained from
Nanolab which were 1-5 µm in length and 20 nm in diameter with a purity larger than
95%. CNT/PLGA scaffolds were fabricated using a solvent casting/particulate leaching
method. Briefly, 30 mg of PLGA (Lectone, 85:15) was dissolved in 300 μl of
CNT/dichloromethane solution. A sonication process was used to uniformly disperse
CNTs in dichloromethane in three concentrations of 1 mg/ml, 3 mg/ml and 5 mg/ml
before adding PLGA. The mixture of PLGA in CNT/dichloromethane was gently
vortexed for 60 mins and sonicated for 30 mins, allowing for the PLGA to fully dissolve
homogenized. Next, the mixture was added into a Teflon mold wells (5.5 mm in diameter
and 2 mm in depth) with 60 mg of NaCl (Sigma) in diameters ranging from 104 to 214
μm. Following the evaporation of dichloromethane for 12 hours, the CNT/PLGA
scaffolds were extracted from the wells of the model, stirred in DI water for 2 days and
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dried at 37 ⁰C in a vacuum oven. The scaffolds were stored in sterile tubes sealed with
parafilm until cellular analysis.

Figure 3. 2 Schematic of salt leaching method. In general, a mixture of porogen
and scaffolding materials in certain solvent was homogenized dispersed and
place in a model. Next, a scaffold without pores were formed in a desired shape
by evaporation of that certain solvent. Lastly, porogen was extract by another
solvent which will not dissolve scaffolding materials and left the space for the
interconnected porous structure.
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3.2.2. Structural, surface roughness and mechanical characterizations of scaffold
The morphology and pore structure of CNT/PLGA scaffolds were evaluated using
scanning electron microscopy (SEM). In brief, scaffolds were attached to sample stubs
and sputter coated with gold. In general, vacuum at 100 Torr has been applied with Ar air
blowing into the vacuum chamber. Au was coated for 30 seconds for the purpose of
conductive. The samples were viewed under SEM at an accelerating voltage of 10kV.
Atomic force microscopy (AFM) in combination with light microscopy was used
to measure the surface roughness of and the degree of CNT aggregation in PLGA films
containing CNTs at various concentrations. Briefly, PLGA was dissolved in a
CNT/dichloromethane solution to give the total CNT concentrations of 1%, 3% and 5%.
CNT/PLGA solution (100 μl) was dipped onto a 1 cm × 1 cm cover slip drop wisely. This
was followed by a 24 h drying at room temperature in a sealed desiccator. AFM
measurements on multiple locations of CNT/PLGA films were obtained using a
NanoScope IIIA MultiMode AFM (Veeco) with contact mode. A scan field of 10 µm ×
10 µm with a scanning rate of 1 Hz was used for these measurements. The data was
analyzed using NanoScope imaging software.
The mechanical strength of three groups of CNT/PLGA scaffolds (5 mm in
diameter and 2 mm in height) with various CNT densities (1%, 3%, 5%) were compared
and controls were carried out using PLGA scaffolds. Compressive modulus testing was
conducted using a mechanical testing machine (ElectroForce 3200) at room temperature
in unconfined compression at 0.05 mm/sec between parallel nonporous plates while
compressive force and displacement were recorded. Based on the monitored strain (σ)
and stress (ε), the compressive modulus (E) was determined using the equation: E=σ/ε.
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3.2.3. Cell seeding
In order to sterilize, scaffolds were immersed in 70% ethanol for 10 min, rinsed
three times with sterile phosphate-buffered saline (PBS) and exposed to UV light for half
an hour on each side. Next, scaffolds were transferred into 24-well culture plates and
seeded with 20,000 MC3T3-E1 (ATCC) osteoblast-like cells per scaffold. Cells were
cultured in α-MEM (Gibco) supplemented with 3 mmol/l glycerophosphate disodium
(Sigma), 10 μg/l ascorbic acid (Sigma), 1% penicillin-streptomycin (Invitrogen) and 10%
fetal bovine serum (FBS) (Invitrogen). Samples were maintained in a humidified
incubator at 37°C with 5% CO2.

3.2.4. Cell attachment, growth, and morphology
At predetermined time points, cell morphology was evaluated using SEM. Cells
on scaffolds containing various CNT densities were fixed in 1% and 3% glutaraldehyde
(Fisher) for 1 h and 24 h, respectively. The scaffolds were dehydrated sequentially by a
series of ethanol concentrations (10%, 30%, 50%, 70%, 90%, 95%, and 100%) for 15
mins each. Scaffolds were then allowed to dry overnight, coated with gold/palladium, and
observed under SEM. For Au coating, For a 30 seconds of Au coating, a vacuum at 100
Torr has been applied with Ar air blowing into the vacuum chamber.
Cell proliferation on scaffolds was assessed using 3-(4,5-Dimethylthiazol-2-yl)2,5-diphenyltetrazolium bromide (MTT) (Alpha Aesar) calorimetric assay. In brief,
scaffolds were washed with PBS, transferred into a new 24 well plate containing 1.5 ml
of fresh culture medium and 300 μl MTT/PBS solutions and incubated at 37°C for 5 h.
This was followed by the removal of medium/MTT solution and addition of 1.5 ml
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dimethyl sulfoxide (DMSO) (Fisher) into each well. The resulting solution was diluted in
a 2:1 ratio using DMSO and the absorbance was read at 550 nm using a Tecan
SpectroFluo Plus reader. The cell number per scaffold was normalized through a
calibration curve.
We used F-actin staining to confirm the cytoskeletal formation of cells on
CNT/PLGA scaffolds. Briefly, cells on scaffolds were fixed at room temperature in 10%
formalin for 30 min. After a 3X wash, cells were permeabilized using a 0.1% Triton X
solution for 5 min. Cells were washed 3X with PBS and blocked using a 1% bovine
serum albumin (Sigma) (BSA) solution for 1 h. TRITC-conjugated phalloidin (1:40)
(Invitrogen) was used to stain the cytoskeletal protein actin for 1 h followed by nuclei
staining with 4’-6-diamidino-2-phenylindole (1:30) (DAPI, Invitrogen). Stained cells
were visualized using a Nikon Eclipse 80i microscope.

3.2.5. Assessment of osteogenic differentiation
Osteogenic differentiation was assessed by monitoring the expression of alkaline
phosphatase (ALP) and deposition of calcium by cells cultured on scaffolds. This was
evaluated for CNT/PLGA scaffolds with CNT densities of 1%, 3% and 5% while PLGA
scaffolds were considered as a control.
ALP activity of the cells was measured quantitatively using an alkaline
phosphatase substrate kit (BioRad). The basic of this method is to convert p-nitrophenyl
phosphate into p-nitrophenyl in the presence of ALP where the rate of p-nitrophenyl is
proportional to ALP activity. Cells were lysed with 1% Triton X-100 in autoclaved water
for 5 min and then the cell lysates were collected and stored at -80⁰C. Upon thawing, 100
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μl of the cell lysate was added to 400 μl of p-nitrophenyl phosphate substrate and buffer
solution mixture and incubated at 37 ⁰C for 30 min. This was followed by addition of 500
μl of 0.4 mol/l sodium hydroxide to stop reaction. The production of p-nitrophenyl was
determined by monitoring the absorbance at 405 nm using a Beckman Coulter DU 730
UV/Vis spectrometer. The ALP activity was normalized by the number of cells on each
scaffold.
ALP activity staining of cells on scaffolds was also accomplished using an
alkaline phosphatase kit #85 (Sigma). Briefly, samples were fixed in 10% formalin
solution for 30 min and washed 3X with PBS. The staining solution was prepared by
mixing the content of Fast Blue capsule in napthanol for 30 min. This was followed by
3X wash in PBS and incubation in the Mayer’s Hematoxylin solution for 10 min. Stained
cells were then photographed using a Nikon Eclipse 80i microscope.
The calcium deposition by cells was quantified using O cresolphthalein
complexone (Sigma) method. In brief, at predetermined time points, the media was
removed. Following a 3X wash with DI water quickly, samples were homogenized with
0.6 mol/l hydrogen chloride. This was followed by 4 h of shaking at 4 oC to extract
calcium. Next, 37.8 ml of 2-amino, 2-methyl, 1-propanol (AMP) was dissolved in 150 ml
DI water and adjusted to pH 10.4 by 6 mol/l HCl in the final volume of 250ml. AMP
buffer were stored in dark at room temperature until use. Color reagent was prepared as
describe: HCI (36.5%) (15 ml) was added to a 250 ml flask containing about 25ml of DI
water. 25 mg 0-cresolphthalein complexone (Sigma) powder was added into the above
prepared HCl solution. 250 mg of 8 hydroxy-quinoline (Sigma) was added as well. The
color reagent was make up to 250 ml with DI water and stored in dark at room
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temperature until use. A series of calcium in different concentration in DI water was
prepared (1 mg/ml, 3 mg/ml, 5 mg/ml, 7 mg/ml and 10 mg/ml) as control.
Then, Tested samples and prepared calcium solution of different concentration,
100 µl each, were placed in 6 well plate with 2 ml AMP buffer and 2 ml color reagent.
Incubated the 6 well plate at room temperature for 15 mins. And the absorbance was read
using a spectrophotometer at 570 nm. A calibration curve was plotted by prepared
calcium solution of different concentration. Calcium content of all tested samples were
calculated accordingly.
Extracellular matrix mineralization was assessed using Alizarin Red S staining
too. In brief, samples were fixed in 10% formalin for 30 min followed by a 3X wash in
DI water. Next, samples were incubated for 5 min in 0.02 mg/ml Alizarin Red S (Sigma)
staining solution (pH: 4.2-4.5). Samples were washed in ethanol and photographed under
a Nikon microscope.

3.2.6. Statistical analysis
Five samples were analyzed per condition. Data in graphs represents mean ±
standard deviation (SD). Comparison between the two means was determined using the
Tukey test and statistical significance was defined as p≤0.05.

57

3.3.

Results and discussion

3.3.1. Characterization of scaffolds

Figure 3. 3 SEM and digital camera images of CNT/PLGA composite scaffolds. (A)
Control PLGA scaffold; (B) 1% CNT incorporated PLGA scaffold; (C) 3% CNT
incorporated PLGA scaffold; (D) 5% CNT incorporated PLGA scaffold; (E)
Photograph of PLGA and CNT/PLGA scaffolds made by salt leaching/particulate
leaching method. White scaffold on the left is a PLGA scaffold and black scaffold on
the right is a 1% CNT incorporated PLGA scaffold. All scaffolds were 5.5 mm in
diameter and 2 mm in height.
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Figure 3. 3 shows SEM images of PLGA (Figure 3. 3A), and 1% CNTs (Figure 3.
3B), 3% CNTs (Figure 3. 3C) and 5% CNTs (Figure 3. 3D) incorporated PLGA
scaffolds, respectively. All scaffolds were highly porous with an interconnected pore
structure. The diameters of cubic pores ranged between 100 μm to 200 μm, as determined
by the NaCl particle size used in scaffold synthesis. Figure 3.3E showed a photograph of
PLGA and 1% CNTs incorporated PLGA scaffold. Scaffolds made from pure PLGA
appeared to be a white disk with a diameter of 5.5 mm and height of 2 mm while the
incorporation of 1% CNTs changed the color of scaffold to black.
Bone tissue engineering strategies rely on the ability to develop 3D porous
scaffolds with mechanical, structural and ECM compositional characteristics of natural
bone. Bone tissue is organized into 5 different tissue type categories: (i) the
macrostructure which is composed of cortical and cancellous bone, (ii) the microstructure
which is made up of osteons, haversian systems, and trabeculae, (iii) the submicrostructure made up of lamellae, (iv) the nanostructure composed mainly of collagen
fibers and (v) the sub-nanostructure which has components such as mineral, collagen, and
other organic proteins [243]. Recreation of the complexity of native bone is major
challenge in scaffold based bone tissue engineering approaches. Further studies are
warranted to elucidate the individual role of scaffold design parameters on the rate of in
vitro osteogenesis and in vivo osteointegration.
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Table 3. 1 Surface roughness of PLGA and CNT incorporated PLGA films
as measured by AFM. The addition of CNTs resulted in an increase in the
roughness of films.
Substrate
RMS (nm)
PLGA film
7.17±1.62
1% CNT incorporated PLGA film
43.95±10.74 *
3% CNT incorporated PLGA film
103.05±9.93 *
5% CNT incorporated PLGA film
169.17±12.72 *
* represents significant difference in surface roughness of CNT/PLGA
films compared to PLGA films at significance levels of p<0.05.

Figure 3. 4 AFM images of PLGA and CNT incorporated PLGA films. (A) Control
PLGA film; (B) 1% CNT incorporated PLGA film; (C) 3% CNT incorporated PLGA
film; (D) 5% CNT incorporated PLGA film. The addition of CNTs led to an increase
in surface roughness and aggregation of nanotubes.
The research work described in this manuscript focuses on the design and
development of CNT/PLGA scaffolds for bone tissue engineering applications. It was
hypothesized that the addition of CNTs to PLGA would combine the enhanced
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mechanical competence of porous scaffolds with the benefits of the increased nano-scale
surface roughness. A rationale for this work was based on recently published reports
demonstrating the extraordinary ability of CNTs to reinforce polymeric composites. This
unique capability stems from high surface to volume ratio and modulus of CNTs [1, 2].
Figure 3. 4 demonstrated the representative AFM images of PLGA and
CNT/PLGA films. Our results demonstrated a direct correlation between the CNT
concentration and surface roughness. The addition of CNTs would significantly increase
the surface roughness of CNT/PLGA composites. Table 3.1 summarized the average
calculated roughness for PLGA and PLGA/CNT films. We observed that the roughness
increases from 7.17±1.62 nm to 43.95±10.74 nm with the addition of 1% CNTs. We
hypothesized that the degree of aggregation and homogeneity in dispersion of CNTs
define the roughness. To confirm this hypothesis, we performed light microscopy of
PLGA films containing CNTs at various ratios. Our results, shown in Figure 3. 4,
demonstrated a homogenous dispersion of single CNTs at 1% ratio and bundling of
CNTs at 3% and 5% ratios to a degree that individual nanotubes become undetectable.
Another major motivation for this study stems from the previous reports
demonstrating the osteogenic properties of CNTs in 2D and 3D systems. In this context,
several groups have attributed the enhanced osteoblast proliferation and unregulated rate
of differentiation to the increased surface roughness resulting from the addition of CNTs
[108-110]. In particular, Zanello et al. recently demonstrated that osteoblasts change
morphology and express plate-shaped crystals in the presence of CNTs [34]. In another
study, osteoblasts exhibit an osteocyte-like morphology as compared to cells cultured on
a glass surface and expressed a higher level of osteogenic differentiation and maturation

61

[104]. The osteogenic effects of nano-roughness has been shown in other systems in
which nanoparticle coated surfaces promoted differentiation through the activation of
mitogen-activated protein kinase (MAPK) pathway [106]. In line with these findings,
Kim et al. demonstrated MAPK to be the dominating pathway in regulating the
osteogenic response of cells to surface roughness on Ti substrates. This effect has also
been demonstrated in 3D scaffolds, where Edward et al. demonstrated a higher degree of
osteogenic differentiation on eletrospun PLGA fibers containing CNTs [112].
We used AFM to confirm that CNT incorporation affects the surface roughness of
scaffolds. We accomplished this analysis in films since the AFM measurements in 2D
yields a more consistent information than 3D scaffolds. Films of PLGA containing CNTs
at concentrations of 1%, 3% and 5% were chosen for this study and the results were
measured in terms of average roughness in nanometers. As depicted in Figure 3. 4 and
Table 3. 1, we observed an increase in roughness of the PLGA films with the addition of
CNTs. This trend was consistent with a previously published report by Tseng et al. in
which they demonstrated the surface roughness of CNT/Polyimide films to increase with
the concentration of CNTs [244]. To illustrate the mechanism behind the impact of CNT
concentration on roughness, we used light microscopy to visualize nanotubes within the
films. At 1% CNT/PLGA ratio, we observed individual nanotubes to create wrinkles
within the PLGA film in all directions leading to an enhanced roughness. With the
increase of concentration to 3% and 5%, CNTs started to aggregate at a higher rate. We
postulate that this phenomenon is responsible for the increased surface roughness of the
films as well as the decreased mechanical strength of scaffolds.
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Figure 3. 5 Compressive modulus of PLGA and CNT incorporated PLGA
scaffolds. * denotes significant difference when CNT/PLGA scaffolds, as
compared to PLGA scaffold (p<0.05) the mechanical strength has been
increased by addition of CNTs. However, CNT content more than 1% leads a
slight decrease in Young’s modulus compared to 1%.
The mechanical properties of scaffolds were assessed by compressive modulus
testing. Interestingly, as shown in Figure 3. 5, CNT/PLGA scaffolds demonstrated a
significantly higher compressive modulus than control PLGA scaffolds. The average
compressive modulus of PLGA, 1% CNT/PLGA, 3% CNT/PLGA and 5% CNT/PLGA
scaffolds were 1.75±0.20 MPa, 6.36±0.55 MPa, 6.0±0.06 MPa and 5.51±0.14 MPa,
respectively. The addition of 1% CNTs into the PLGA scaffolds resulted in 3.6 fold
increase in compressive modulus demonstrating the potential of CNTs as to fabricate
composite scaffolds with desired mechanical strength.
In this study, we used solvent casting/particulate leaching to develop scaffolds. A
major advantage of this fabrication method is that it allows for control over the porosity
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and pore size through the use of NaCl particles with selective size ranges [245]. In line
with our hypothesis, the results demonstrated a 3.4 fold increase in compressive modulus
with the addition of 1% CNTs to PLGA scaffolds. Interestingly, the higher CNT ratios
led to a decrease in mechanical strength. We attribute the reduction in mechanical
strength of scaffolds to the aggregation and heterogeneous distribution of CNTs within
the scaffolds. The tendency of CNTs to aggregate stems from their nano-structure, van
der Waals interaction and limited dispersibility [246] It is important to note that this
phenomenon has been also observed in other studies on mechanical properties of
composites. For instance, Narimissa et al. showed a gradual decrease in Young’s
modulus of graphite/PLA nanocomposite due to aggregation of graphite [247]. In another
study, Saotome et al. demonstrated a reduction in modulus with as larger fullerene nanoparticple aggregates formed within the polycarbonate nanocmposites [248]. Take a step
forward, we used percolation theory to explain the mechanical behavior of our scaffolds.
This theory allows for calculating the threshold that describes the critical volume fraction
separating the two phases in the mixture. Interestingly, the percolation threshold for
CNT/polymer system is dependent on size and distribution of CNTs [249, 250].
Specifically, the percolation threshold for a rod-like filler for mechanical enhancement
could be calculated according to this equation: Vfc=0.7/(L/d). Where L and d represents
length and diameter of a filler [251, 252]. Since our CNTs are 1-5 um in length and 20-40
nm in diameter, the calculated threshold is about 1.2%. Consequently, a drop of Young’s
modulus has been observed when more CNTs than 1% was added into scaffolds.

64

3.3.2. In vitro evaluation of CNT/PLGA scaffolds

Figure 3. 6 Cell attachment on PLGA and CNT/ PLGA films after 1 day of cell
seeding. * denotes significant difference in cell number on CNT incorporated
PLGA scaffolds compared to PLGA scaffolds (p<0.05) the cell number adhere
to film has been increased by addition of CNTs. However, CNT content more
than 1% leads a slight decrease in the number of cell attachment compared to
1%.

To assess the effect of CNTs on initial cell attachment, we measured cell number
on PLGA, 1% CNT/PLGA, 3% CNT/PLGA and 5% CNT incorporated PLGA films after
4 hours of cell culture (Figure 3. 6). Average cell number attached on films showed an
increase with the addition of CNTs to PLGA. Cell number appeared to be highest on 1%
CNT/PLGA films demonstrating a 2.9 fold increase per mm2 compared to PLGA.
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Figure 3. 7 SEM images of MC3T3-E1 osteoblast morphology and growth on PLGA
(A and C) and 1% CNT/PLGA scaffolds (B, D) at days 7 and 21 respectively. No
significant difference in cell morphology was noticed between the two groups.
Cell morphology and growth on scaffolds were visualized using SEM (Figure 3.
7). Cells first attached to the wall of pores and formed cell bridges between cell walls. All
of the scaffolds were fully confluent after 7 days meanwhile pores could still be seen. At
day 21, we observed a layer of cells covering the surface of scaffolds and filling the pore
spaces.
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Figure 3. 8 MC3T3-E1 osteoblast proliferation on TCPS, PLGA and CNT
incorporated scaffolds. *, + and ^ represents significant difference in cell
proliferation on CNT/PLGA scaffolds compared to PLGA scaffold at the same
time point at significance levels of p<0.05, p<0.1 and p<0.5, respectively.
Cell proliferation on 3D scaffolds was assessed quantitatively using MTT assay,
as presented in Figure 3. 8. Four groups of PLGA, 1% CNT/PLGA, 3% CNT/PLGA and
5% CNT/PLGA scaffolds were considered for this study. Tissue culture polystyrene
(TCPS) control group was included to confirm the status of cell culture conditions. The
data presented growth in cell number as a function of time for all the groups. Strikingly,
the incorporation of CNTs into the scaffolds resulted in a significant increase in cell
proliferation for all time points and reached a plateau at day 28. Consistently in all time
points, the maximum increase in cell proliferation as compared to PLGA scaffolds was
observed in scaffolds containing 1% CNTs.
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Figure 3. 9 Immunofluorescent staining of (A-B) nuclei, (C-D) cytoskeletal
protein actin, and (E-F) actin-nuclei double staining of MC3T3-E1
osteoblasts cultured on PLGA (left column) and 1% CNT/PLGA (right
column) scaffolds for 21 days. No significant difference in cell morphology
was noticed between the two groups.
Cell cytoskeletal organization and morphology within the scaffolds were
visualized via immunofluorescent staining with nuclei DAPI and cytoskeleton protein
actin. Figure 3. 9 illustrates cell nuclei and actin double staining of cells cultured on
PLGA and composite CNT/PLGA scaffolds. We observed that cells proliferated on the
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surface and within the pores of scaffolds. There was not a noticeable difference in
cytoskeletal organization between the control and CNT incorporated scaffolds.

Figure 3. 10 Alkaline phosphatase activity and calcium
expression of MC3T3-E1 osteoblasts on PLGA and
CNT/PLGA scaffold. *, + and ^ represents significant
difference in ALP activity and calcium expression by
cells on CNT/PLGA scaffolds compared to cells on
PLGA scaffolds at the same time point at significance
levels of p<0.05, 0.1 and 0.5, respectively. A slight
increase of calcium content was observed in first two
weeks and a sharp leap of calcium content in after that. A
moderate increase of ALP activity was observed through
4 weeks.
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Osteogenic differentiation of cells was assessed by quantifying ALP activity and
calcium content combined with qualitative Alizarin red mineral and ALP staining. Figure
3. 10A showed ALP expression level by cells grown on control PLGA scaffolds as well
as scaffolds containing 1%, 3%, and 5% CNTs.

Figure 3. 11 (A-B) Alizarin red S staining and (C-D) alkaline phosphatase staining of
MC3T3-E1 ostoblasts on PLGA (left) and 1% CNT/PLGA scaffold (right) at day 21.
Calcium and ALP staining were showed positively, respectivly.
For all groups, ALP expression increased as a function of time. While the addition
of CNTs resulted in enhanced osteogenic differentiation, the group containing 1% CNTs
demonstrated the highest level of ALP expression. These results were consistent with the
results of calcium content quantification (Figure 3. 10B). The data demonstrated an
increase in calcium content on control PLGA scaffolds as well as PLGA scaffolds
containing CNTs as a function of time. Strikingly, 1% CNT/PLGA scaffolds
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demonstrated the highest amount of calcium with 1.5 fold higher level than control
PLGA scaffolds after 28 days of culture.
We confirmed the mineral deposition and ALP expression by cells cultured on
PLGA and 1% CNT/PLGA scaffolds, as demonstrated in Figure 3. 11. It was observed
that cells express ALP enzyme and deposit mineral on the surface and within the pore
spaces of scaffolds. Interestingly, the addition of CNTs to the scaffolds resulted in a
faster rate of mineralization and higher rate of ALP expression by cells. These results all
together demonstrate that CNTs enhance early stage osteogenic differentiation and late
stage mineralization of osteoblastic cells on 3D PLGA scaffolds.
In line with other published reports, our in vitro results demonstrated a higher
degree of MC3T3-E1 osteoblast-like cell adhesion and proliferation rate on PLGA
scaffolds containing CNTs. The decrease of number of cell attachment accompany with
more addition of CNT was due to that agglomeration of CNTs. More dispersed CNTs are
preferred for cell attachment. Moreover, large agglomeration will also decrease the
available surface area for cell attachment as well. Progressive osteoblast proliferation was
observed throughout the scaffold 3D structure and resulted in the formation of cellular
extensions covering the entire scaffolds and filling the pore spaces. Cell growth
quantification results were consistent with the immunofluorescent images of actin
cytoskeleton in showing osteoblasts preserved cellular structure integrity throughout the
scaffolds. When exposed to the differentiation media, cells underwent osteogenic
differentiation in 28 days on both control PLGA and CNT/PLGA scaffolds. Our scaffolds
shows a good biocompatibility to MC3T3-E1 osteoblast-like cells.
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The extent of differentiation was assessed through quantification of ALP activity
and calcium content combined with qualitative Alizarin red mineral and ALP staining.
ALP activity is an early marker of osteogenesis, which usually dominates in the first two
weeks. Calcium content is the late marker for osteogenesis, which usually dominates after
two weeks. We did observed a slow increase of calcium content on Day 7 and Day 14
and a sharp leap of calcium content in after that on Day 21 and Day 28. However, we
didn’t observe any ALP activity drop on Day 21 and Day 28. This was because the cells
were mature outside from inside at a different rate. Cells in the middle of scaffold were
migrated slowly into and need more time mature due to oxygen and nutrition limitation.
Moreover, our results collectively showed that the presence of CNTs led to a
significant elevation in expression of osteogenic markers. This was manifested in
quantified ALP and calcium content measurements as early as day 7. Interestingly,
scaffolds containing 1% CNT stimulated the growth and differentiation of osteoblastic
cells at the highest rate. The mechanism of the stimulatory effects of CNTs and inhibitory
effects of high CNT loading is yet to be determined. However, this can be attributed to
the higher surface roughness and stiffness as well as the excess bonding of growth factors
to CNTs. Further studies are warranted to elucidate the mechanisms by which CNTs
modulate protein adsorption and the consequent stem cell response to exogenous
adsorbed growth factors.
The enthusiasm for the biomedical applications of CNTs has been dampened for
toxicity concerns. In general, the toxicity of CNTs has been reported to be function of
high surface area and intrinsic surface properties [253]. A recent report by Donaldson et
al. demonstrated that CNTs are harmful to lung and illicit immunological responses [254].
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Further studies by this group showed that long term inhalation of CNTs will cause
pulmonary tumors. In another report, the fullerene distributed in tissues accumulated
rapidly in liver and spleen [255]. However, recent work by Mikael et al. suggested that
CNTs in low concentration and high purity evoke minimum cytotoxicity [256].
Tremendous effort has gone to characterize the nature of CNTs toxicity and modify the
surface properties of CNTs to diminish their adverse effects. An approach to accomplish
this goal is the functional modification of CNTs to enhance dispersion in physiological
solutions as well as excretion of CNTs from human body. Singh et al. recently
demonstrated that CNTs functionalized with carboxylate and hydroxyl groups had
varying affinities for liver, kidney, spleen and bone, and can be cleared through renal
excretion route [257]. Our observations in this study provide the proof of principle for the
use of CNTs combined with osteoblasts in treatment of bone disorders. A future
extension of this study will include the modification of CNTs to diminish toxicity side
effects.
Another future direction of this research involves studies on how to control the
orientation of CNTs within 3D scaffolds. Alignment allows for control over the extent of
cell spreading and regulation of phenotype. This has been demonstrated in 2D
environments where the orientation of CNTs distributed on a surface impacted the
directional migratory behavior as well as osteogenic differentiation of MSCs. The
incorporation of CNTs also provides an opportunity to regulate phenotypic expression
and lineage specification of stem cells by electrical cues. Earlier attempts to accomplish
this goal led to the fabrication of CNT-based nanodices for neural as well as cardiac
electrical stimulation [258, 259].
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3.4.

Conclusion
In this study, mechanically competent CNT/PLGA scaffolds were fabricated

through a uniform dispersion of CNT in PLGA/dichloromethane solution followed by a
solvent casting and particulate leaching step. The incorporation of CNTs allowed for
tuning the mechanical strength without compromising the porous architecture of
scaffolds. The in vitro potential of CNT/PLGA composite scaffolds for bone tissue
engineering was evaluated by monitoring the behavior of MC3T3-E1 osteoblasts. Our
results demonstrated that the addition of CNT to PLGA scaffolds leads to a significant
increase in adhesion, growth and osteogenic differentiation of cells. We were able to
confirm the coupling of matrix stiffness and mechanical strength to enhanced
osteogenesis in 3D environment. Interestingly, scaffolds containing 1% CNT
demonstrated the highest level of in vitro bone mineralization due to a more uniform
distribution of CNTs throughout the PLGA scaffolds. These findings all together
demonstrate CNTs to be a powerful tool in scaffolds design in stem cell based tissue
engineering. A more detailed study is warranted to delineate the signaling mechanisms by
which CNTs regulate osteogenesis.
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CHAPTER 4

PLGA-Carbon Nanotube Conjugates for Intercellular Delivery of Caspase-3 into
Osteosarcoma Cells

4.1.

Introduction
Cancer is a principal concern in today’s health care treatment with more than 10

million cases each year [260]. Oncologists generally utilize physiological intervention as
well as chemical and radioactive therapeutics to treat different forms of cancer. The
drawbacks to the current therapeutics are the removal or necrosis of healthy tissue in
addition to the tumor tissue. These side effects are one of the major concerns for
traditional cancer treatments. To this end, targeted drug delivery has paved another
avenue in potential cancer therapy in recent years. The Food and Drug Administration
(FDA) approved clinical gene therapy in the 1990s [79] and in experimental and clinical
stages has since demonstrated the promise of drug delivery in curing human diseases.
Retrovirus [81], adenovirus [82] and adeno-associate [83] viral vectors are the major
types of gene vectors used in research today. Although viral vectors are efficient in both
delivery and transduction of cells, there are concerns that these viruses are sourced from
lethal diseases such as human immunodeficiency virus (HIV) and human T-cell
lymphotropic virus (HTLV). A safe, inexpensive, and effective vector has yet to be
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fabricated for use in gene therapy. Therefore, developing these safe and efficient delivery
systems in a controlled manner is a major focus and challenge in research [80].
The enhanced permeability and retention (EPR) effect, which is inherent to tumor
biology, can allow nano-sized drug carriers to accumulate, retain, and release drugs due
to the fact that tumors have leaky blood vessels and poor lymphatic drainage [261]. In
further researching nano-sized drug carriers, scientists have been able to begin to widen
the window into the dark room of cancer therapy. The use of nano-sized drug carriers has
a few key advantages including the protection of delicate drugs, enhanced absorption in
selective tissues, controlled drug distribution profile, and enhanced intracellular
penetration [123]. Thus, researchers have taken initiative and developed several methods
to fabricate nano-sized drug delivery carriers.
Polymers and lipids have garnered the most attention thus far as materials for
drug delivery. Synthetic polymers such as poly (ethylene glycol) (PEG) [84], poly (lactic
acid) (PLA) [85] and PLGA [86] as well as natural polymers such as chitosan [87],
collagen [88], gelatin [89] or lipids [262] can be fabricated as nanoparticles, liposomes,
and micelles to deliver molecules by either chemical modification or physical absorption.
Drugs are able to be released in a controlled manner due to either surface and bulk
degradation or phase transition principles. However, there are concerns with these due to
immune responses dealing with the heterogeneity of the materials used as well as the low
transfection efficiency and specificity. In noting this, we sought to develop a highly
efficient non-viral vector drug delivery system utilizing CNTs.
CNTs [2], silicon nanowires [263], gallium nanotubes [264], boron nitride
nanotubes [265], titanium oxide nanotubes [266] and zinc oxide nano-rods [267] have
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received an overwhelming amount of support and enthusiasm in biomedical research.
CNTs are made of a layer of grapheme [268] and have been used to shuttle several
different biological molecules, ranging from small drug molecules [125] to
biomacromolecules such as proteins [127], DNA [128, 269] and RNA [130] into different
types of cells via endocytosis efficiently[131]. Ricin A was also delivered into various
cell line with conjugation of CNTs and induce cell death. Other than cell proliferation
inhibition and induction of cell death, DNA plasmids were also delivered into cells and
enhance certain gene expression. CNTs are able to easily penetrate the cells and give the
opportunity to transport this biological cargo across the cell membrane due to an
extremely high aspect ratio. However, health concerns have hampered the practical
application of using inorganic CNTs in biological applications thus far. Toxicity issues
still raise doubts about the practical applications of CNTs due to the intrinsic toxicity
caused by a high surface area and hydrophobicity [253]. However, toxicity concerns may
not be a critical issue in cancer therapy due to that (a) EPR effect will accumulate
nanoparticles in tumor tissue only; (b) The potential toxicity of CNTs would be
acceptable due to cancer therapy target on killing cancer cells; and (c) CNTs at small
amounts or functionalized with other molecules have shown to evoke minimum toxicity
to normal cell line [256, 257]. Therefore, functionalization of CNTs can prove to be a
successful path to protein and gene therapy. For instance, Liu et al. have been able to
successfully deliver siRNA with phospholipid PEG (PL-PEG) functionalized CNTs into
tumor cells and tissue to inhibit tumor cell proliferation, tissue ingrowth, and CXCR4
expressions both ex vivo and in vivo [132-134]. siRNA was released by breaking the S-S
bond, which attached the siRNA to PL-PEG. Other pristine CNT based delivery vectors
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are able to rely on diffusion to unload biological cargoes [127, 128, 130, 269]. Although
the cellular uptake mechanism may differ depending on the functionalization and size of
CNTs [124], thus far the researchers have been unable to control the release profile in a
specified manner.
In this study we hypothesized a method to engineer a novel CNT based delivery
vector functionalized with a degradable PLGA coating. Through degradation of PLGA,
transcription factors are able to be released in a controlled manner and tune cell behavior.
Significant advantages to our proposed system include the ability to transfect cells
efficiently with the unique needle-like shape of CNTs, reduce cytotoxicity of pristine
CNTs through a biocompatible PLGA coating, and program protein release times by
controlling the degradation profiles of the PLGA.

4.2.

Materials and methods

4.2.1. Carbon nanotube carboxylation
CNTs (0.2g) were purchased from Nanolab Inc. with an average length of 1-5
µm, diameter of 15±5 nm, and purity higher than 95% was added into a single neck glass
flask with 200 ml 70% nitric acid (Fisher). For carboxylation of CNTs, CNTs were
homogenously dispersed in nitric acid by sonication for 60 minutes at ambient
conditions. A condenser reflux apparatus was followed to equip on top of single neck
glass falsk to prevent CNTs in nitric acid from drying out. A silicon oil bath was set up to
heat up the oxidation experiment. The reaction temperature was set at 120 oC for 12
hours. The reaction was quenched by addition of 200 ml deionized (DI) water. The
mixture was filtered by 0.45 µm cellulose filter paper (Fisher), washed with DI water to
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neutral pH, and dried at 80 oC overnight [175]. The black leftover on filter paper was
stored in a glass vial sealed with parafilm in a desiccator until use.

4.2.2. PLGA functionalization
Carboxyl CNTs (50 mg), as prepared in 4.2.1., were homogeneously dispersed in
50 ml dimethylformamide (DMF) (Fisher) by sonication for 2 hours at ambient
conditions. A total of 2 ml oxalyl chloride (Acros) was added drop wisely under N2 and
stirred in ice water for 2 hours with a magnetic stirrer. This mixture was stirred for
another 2 hours at room temperature. A CNT-acyl chloride has been formed. Then, the
mixture was transferred into a silicon oil bath at 70 oC and stirred overnight to remove the
excess of oxalyl chloride. PLGA (0.5 g) (75:25) (Lactel) was then added and stirred at
100 oC for 5 days. CNT-PLGA was then formed by that chloride of CNT-acyl chloride
was replaced by PLGA through a nucleophilic reaction. Finally, the CNT-PLGA
containing solution was cooled down, filtered by 0.45 µm cellulose filter paper (Fisher),
and washed with DMF, ethanol (Decon Labs), and DI water. The PLGA linked CNTs
(CNT-PLGA) were the black leftover on the filter paper and were dried at 80 oC
overnight, collected and stored in a glass vial sealed with parafilm in a desiccator [177].

4.2.3. Protein attachment
CNT-PLGA (100 µg) was dispersed in 0.5 ml of 2-(N-Morpholino)ethanosulfonic
acid (pH 5.6) (MES) (Acros) buffer under sonication for 1 hour at ambient conditions.
0.25 ml of 1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (0.2 mol/L)
(EDC) (Acros) and 0.25 ml of N-Hydroxysuccinimide (0.1 mol/L) (NHS) (Acros) in
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MES solution were added to the activated carboxylate groups [170, 171]. EDC reacts
with a carboxyl group on CNT-PLGA, forming an amine-reactive O-acylisourea
intermediate. This intermediate may react with an amine on proteins, yielding CNTPLGA-protein conjugates. However, the intermediate is also susceptible to hydrolysis,
making it unstable and short-lived in aqueous solution. The addition of NHS stabilizes
the amine-reactive intermediate by converting it to an amine-reactive NHS ester, thus
increasing the efficiency of EDC-mediated coupling reactions. Finally, the aminereactive NHS ester intermediate has sufficient stability to form CNT-PLGA-protein
conjugation in aqueous solution.
The mixture was washed with PBS and centrifuged in a 100 KDa molecular
weight cutoff centrifugal filter (Millipore) to remove EDC and NHS at 5000 g three times
for 30 mins. Then, 5 µg of protein, either bovine serum albumin (BSA) (Sigma),
fluorescent BSA (fBSA) (Sigma), or caspase-3 (CP3) (BD) was added into the CNTPLGA/PBS solution at 4 oC overnight. The mixture was finally washed and centrifuged
in a cutoff filter to remove un-conjugated protein six times at 5000 g for 30 minutes
[171]. The protein conjugated CNT-PLGA (CNT-PLGA-CP3/BSA/fBSA) solution was
collected and stored at -20 oC.
Pro-Ject protein transfection kit (BD) was used as a reference. Liposomes
nanoparticles were fabricated through the commercial manual. Note that the actual
protein amount dosages were calculated equally to the amount CNT-PLGA-CP3 groups.
In general, certain amount of caspase-3 was dissolved PBS. Dry Pro-Ject film was
hydrated and dispersed well by caspase-3 containing PBS solution. The mixed solution
was incubated at room temperature for 5 mins and ready to be used. According the BD
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protocol provided. An incubation time of 3-4 hours in serum free medium was required
for protein transfection. 96 well plate was used for Pro-Ject transfection control. 20, 000
cell/cm2 cell seeding density was used.

4.2.4. Cell culture
Osteosarcoma cells MG-63 (ATCC) were cultured in 90% α-MEM (Lonza) and
10% FBS (Gibco) supplemented with 2 mmol/ml l-glutamine (Sigma). A serum free
medium mentioned above was prepared without serum using the same recipe. Cells were
placed in well plate with a seeding density of 20,000/cm2. Testing conjugates were
introduced after 4 hours. This time point was set as 0 and cells were then maintained in a
humidified incubator at 37°C with 5% CO2.

4.2.5. MTT assay
Cell

viability

was

assessed

using

3-(4,5-Dimethylthiazol-2-yl)-2,5-

diphenyltetrazolium bromide (MTT) (Alpha Aesear) calorimetric assay at predetermined
time points of 1, 3, 5 and 7 days. In brief, MTT/PBS solution was added into each well
(1:5) and incubated at 37 °C for 5 h. This was followed by the removal of medium/MTT
solution and addition of 1 ml dimethyl sulfoxide (DMSO) (Fisher). The resulting solution
was diluted by DMSO in a ratio of 4:1 and the absorbance was read at 550 nm using
Tecan SpectroFluo Plus reader. Cell viability was determined as the equation:
Cell Viability=

Abs550nm of Treated Sample
 100%
Abs550nm of Control
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4.2.6. Spectra measurement
XRD patterns were carried out on a Rigaku MiniFlex II with a scanning speed of
0.2 degree/minute. UV was measured on a Jasco UV 60 UV-Vis spectrometer from 250
to 500 nm. Fourier Transform Infra-Red (FTIR) spectrum was measured on a Nicolet
6700 FT-IR spectrometer from 3600 to 400 cm-1.

4.2.7. Immunofluorescent images
To remain sterile, cover slips were rinsed in 70% ethanol for 10 minutes and
washed with PBS. Cells were seeded onto cover slips and allowed 12 hours to expand on
glass slides. The addition of 0.05, 0.1, 0.5, 1 and 3 µg/ml CNT-PLGA-fBSA conjugate
was added and incubated for 4 hours. Then samples were washed with PBS, fixed with
formalin (Sigma), and dried. Fluorescent images were taken with a Nikon Eclipse 60i
microscope system and all images were analyzed with Nikon Elements NX4 software.

4.2.8. TEM
Cells were seeded onto 40 mesh carbon grids for 12 hours with a density of
20,000 cells/cm2 followed by an addition of 3 µg/ml CNT-PLGA-BSA conjugate
solution and incubated for 4 hours. Samples were then washed with PBS, fixed with
formalin, and dehydrated by a series of ethanol treatments [164]. TEM images of the cell
penetration of the CNT-PLGA-BSA conjugate were taken with a Hitachi H8000 TEM.
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4.2.9. Temporal release profile of BSA from CNT-PLGA-BSA in vitro
CNT-PLGA (100 µg) was dispersed in 0.5 ml of 2-(N-Morpholino)ethanosulfonic
acid (pH 5.6) (MES) (Acros) buffer under sonication for 1 hour at room temperature.
0.25 ml of 1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (0.2 mol/l)
(EDC) (Acros) and 0.25 ml N-Hydroxysuccinimide (0.1 mol/l) (NHS) (Acros) in MES
solution were added to the activated carboxylate groups [170, 171]. The mixture was
washed with PBS and centrifuged in a 100 kDa molecular weight cutoff centrifugal filter
(Millipore) to remove EDC and NHS at 5,000 g three times for 30 minutes. Then, 200 µg
of BSA was added to the CNT-PLGA/PBS solution at 4 oC overnight. Lastly, the mixture
was washed and centrifuged in a cutoff filter to remove un-conjugated BSA six times at
5,000 g for 30 minutes [171]. The removed filtered solution was collected each run to
determine amount of loaded BSA.
The CNT-PLGA-BSA conjugates were then dispersed in 1 mL PBS by sonication
(5 min) and incubated in a water bath (37 oC). The entire conjugate solution was
centrifuged in a 100 kDa molecular weight cutoff centrifugal filter (Millipore) to remove
the released BSA solution at each predetermined time point. The concentration of the
released BSA was determined with a Jasco UV 60 UV-Vis spectrometer at 280 nm with a
pre-made calibration curve.

4.2.10. Release of resveratrol from nanoparticles made of different PLGA in vitro
In general, 100 mg of PLGA (Lactel) in differing ratios of PLA to PGA and
molecular weight (5,000-16,000/50:50, 16,000-29,000/50:50 and 75,000-100,000/75:25)
along with 10 mg of resveratrol (Sigma) were dissolved in 5 mL acetone (Sigma). The

83

mixture was then slowly injected into 100 mL 0.25 mol/ml MES solution (pH 5.0)
containing 2.5% PVA (Sigma) at a rate of 1 mL/min [170, 171]. After 24 hours of
moderate stirring to remove traces of acetone, the nanoparticle solution was centrifuged 6
times to remove the non-incorporated resveratrol. The supernatants were collected to
determine the loaded resveratrol. The collected nanoparticles were lyophilized and stored
in a desiccator.
The nanoparticles (1mg) were dispersed in 1 mL PBS by sonication (5min) in an
EP tube and incubated in a water bath (37 oC). The nanoparticle suspension was
centrifuged to collect the supernatant at each predetermined time point. The concentration
of released resveratrol was determined with a Jasco UV 60 UV-Vis spectrometer at 327
nm with a pre-made calibration curve (Supplementary Figure 3).

4.2.11. Statistical analysis
Five samples were analyzed at each condition. Data in graphs represents the mean
± standard deviation (SD). Comparison between the two means was determined using the
Tukey test and statistical significance was defined as p ≤ 0.05.

4.3.

Result and discussion

4.3.1. PLGA functionalization
CNTs have been used previously to deliver biological materials across the cell
membrane including proteins, DNA, and RNA. Developing the proper surface
functionalization for CNTs is the most critical step for a desired application. The two
major types of functionalization for CNTs are non-covalent and covalent bonds [52].
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Non-covalent binding is based on π-π stacking between the CNTs and aromatic groups
from the linkers [180]. Liu et al. showed previously that DNA could be immobilized on
pyrene derivatives of functionalized CNTs [270]. Other than these pyrene derivatives,
single stranded DNA can also be used to immobilize CNTs [271], however DNA can be
cleaved by serum, suggesting non-covalent reactions may not be stable in some cases
[181]. For covalent binding, reactive groups are usually formed by various oxidation
methods [175, 176] which allow for further modifications to enhance polymer [177],
protein [178] and DNA [132] attachment. Functionalized CNTs can also be easily
dispersed in water, which allows for forming supermolecular bioconjugates such as
PLGA and PEG. PLGA is a FDA approved polymer for clinic use with the unique ability
to control degradation rate, which allows us to tune the drug release profile. PEG is
another commercially manufactured clinic material which has been used to conjugate
with CNTs to deliver siRNA by the instant cleavage of S-S bond. PEG has only one type
of functional group and smaller average molecular weight compared to PLGA. Further
modifications are required to attach active biological cargoes to PEG and control its
release profile. To this end, a novel CNT-PLGA based drug delivery system has several
advantages including a high transfection rate, reduced toxicity, and a highly controlled
drug release profile.
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Figure 4. 1 Schematic of drug delivery into cells, carbon nanotubes is oxidized to form
new carboxyl groups, linked with PLGA and functionalized by caspase-3. The
conjugates penetrated into MG-63 cells and release caspase-3 by degradation of
PLGA.
In this study, a novel CNT based drug delivery system as depicted in Figure 4. 1
was developed. In general, pristine CNTs as shown in Figure 4. 2 were oxidized in nitric
acid to form carboxyl groups. Carboxyl groups of CNTs were then activated by oxalyl
chloride forming CNT-acyl chloride and attached to the PLGA [177]. PLGA is able to
provide attachment for the desired transcription factor CP3 by replacing chloride. The
CNT-PLGA-CP3 conjugate can be easily dispersed in PBS without aggregation, which
otherwise would hinder penetration of the cell membrane. Due to the enzymatic
degradation of PLGA, CP3 would is able to be released gradually and induce cell
apoptosis. The CNT-PLGA-CP3 conjugations are stable for weeks at -20 oC and the
delivery profile can be tuned simply by changing the concentrations of PLGA.
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Figure 4. 2 TEM image of carbon nanotubes. The result showed
that pristine carbon nanotubes has no outside coating. Our CNTs
are about 5 µm in length with a diameter about 20 µm.
XRD, UV, IR and TEM were used to investigate the CNT-PLGA complex. In
Figure 4. 3A, all XRD patterns were roughly the same in the region larger than 35
degrees which represents the crystal structure of the C-H bond, sp2 hybrid C-C bond, and
C-O bond [3]. However, PLGA patterns showed a peak, which denoted the amorphous
region of PLGA polymers from 10-25 degree as shown in Figure 4. 3B. This peak can be
determined as a characteristic of PLGA, which CNTs alone do not possess. A small peak
at 22.7 degree for amorphous PLGA and a peak at 24.1 degree for CNTs were observed,
indicating PLGA attachment to CNTs. However, this peak was not as pronounced as
observed in pattern A. We believe only small amounts of PLGA were able to bind to
CNTs resulting in a decreased signal.
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Figure 4. 3 Characterization of CNT-PLGA complex. A is XRD pattern, B is XRD
pattern as well. C is UV-Vis spectrum, D is TEM image. Results showed that
PLGA is successfully attached to carbon nanotubes. A small peak at 22.7 degree for
amorphous PLGA and a peak at 24.1 degree for CNTs found in XRD pattern were
indicating PLGA attachment to CNTs. UV absorption at 260 nm of CNT-PLGA
indicated PLGA and CNTs were present. Dark PLGA layer clearly shown coated
over the CNTs with a depth of several nanometers by TEM.
CNTs have a simple flat UV absorption and start to decrease from 280 nm as
shown in Figure 4. 3C. PLGA didn’t show a similar trend instead showing a strong
absorption at 260 nm similar to Cheng’s finding [272]. CNT-PLGA showed absorption at
260 nm indicating PLGA and a flat decreasing trend thereafter, indicating CNTs were
present. This finding showed a similar trend to CNT-Paclitaxel [133]. Through FTIR
spectra CNTs showed a typical sp2 hybrid C-C stretching at 1200 cm-1, while no O-H
stretching was observed at 3400 cm-1 as shown in A. On the contrary, O-H stretching and
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C=O stretching at 1650 cm-1 were observed in CNT-PLGA. This denoted a successful
attachment of PLGA to the CNTs. In addition to FTIR, TEM was used to observe the
PLGA linkage to CNTs. Pristine multi-wall CNTs in Figure 4. 2 with no PLGA
functionalization was compared to the dark PLGA layer clearly shown coated over the
CNTs with a depth of several nanometers in Figure 4. 3D.

4.3.2. Protein attachment

Figure 4. 4 Characterization of protein conjugation. A is Infra-red spectrum, B
is light microscopy of CNT-PLGA-BSA, C is fluorescent images of CNTPLGA-fBSA. Results showed that proteins has been successfully attached to
CNT-PLGA complex, forming CNT-PLGA-BSA conjugates. CNT-PLGABSA showed a peak around 1400 cm-1 indicating amide III belt in IR, which is
the typical peak of BSA. A single CNT-PLGA attached to fBSA was observed
through immunofluorescence indicating successful conjugation.
DNA and RNA are the genetic material generally transported by functionalized
CNTs. In 2004, Pantarotto discovered CNTs as a tool to transport DNA plasmids [128].
Further research found DNA was protected by CNTs during cellular uptake [273]. In
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addition, Zhang et al. successfully transported telomerase inhibited small interference
RNA into tumor cells and suppressed their growth [274]. However, researchers generally
used protein fictionalization for stabilizing [275], labeling [276] and separating [277]
CNTs rather than transporting functional protein to tune cellular behavior. Here, we were
able to conjugate protein to CNT-PLGA complex.
Protein typically has a UV absorption at 280 nm due to sp2 hybrid C-C in Phe,
Tyr, and Trp which is a similar structure to CNTs. Protein also has a similar amorphous
region in XRD pattern as most polymers. Therefore, XRD and UV are not appropriate
methods to confirm protein attachment so we used FTIR and fluorescently tagged BSA to
confirm the attachment of protein. As shown in Figure 4. 4A, CNT-PLGA-BSA showed a
peak around 1400 cm-1 indicating amide III belt, which is the typical peak of BSA. fBSA
was then used to attach to CNT-PLGA and in Figure 4. 4B and Figure 4. 4C, a single
CNT-PLGA attached to fBSA was observed through immunofluorescence indicating
successful conjugation. CNTs are generally auto fluorescent over 800 nm [278] but no
fluorescent signal was observed at those wavelengths confirming the protein attachment.

4.3.3. Cellular transfection by CNT-PLGA-fBSA conjugates
The ideal vector to deliver biological material should have two basic
characteristics being high efficiency and safety. In terms of efficiency, we investigated
the cellular uptake ability of CNT-PLGA-fBSA and CNTs were found to have the ability
to penetrate cells due to their nano-sized diameter and small radius to volume ratio [279].
In demonstrating the high efficiency to penetrate cells, we tested the transfection ability
of CNT-PLGA-fBSA conjugations in different dosages.
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Figure 4. 5 Optic and fluorescent combined images of CNT-PLGA-fBSA delivery into
MG-63 osteosarcoma cells. All images are 20 X. The dosage culture with osteosarcoma
cells are 0.05 g×ml-1, 0.1 g×ml-1, 0.5 g×ml-1, 1 g×ml-1 and 3 g×ml-1, respectively.
The results showed that CNT-PLGA-fBSA can easily penetrate into cells and transduce
osteosarcoma cells. The CNT-PLGA-fBSA conjugates showed a pronounced ability to
penetrate cells with a transfection rate close to 100% at all conducted concentrations,
ranging from 0.05 to 3 g/ml.
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In order to prevent non-specific background signals, cells were carefully washed
to remove any non-penetrated CNT-PLGA-fBSA conjugates. We were able to observe
fluorescent signals in cells as shown in Figure 4. 5. The CNT-PLGA-fBSA conjugates
showed a pronounced ability to penetrate cells with a transfection rate close to 100% at
all conducted concentrations, ranging from 0.05 to 3 g/ml.

Figure 4. 6 Determination of carbon nanotubes delivered into osteosarcoma cells.
The dosage 3 g×ml-1. A is osteosarcoma cells cultured with CNT-PLGA-fBSA. B
is image of fluorescent signal within osteosarcoma cells. C is the optic and
fluorescent combined image of CNT-PLGA-fBSA image. D is the TEM image of a
single CNT-PLGA-BSA penetrating the cell body. The results showed that the
conjugates penetrate the cells.
The high magnification images of Figure 4. 6A, Figure 4. 6B, and Figure 4. 6C
were able to show higher resolutions around the nuclei which showed higher fluorescent
signal, coinciding where large amounts of ribosomes reside. This location of the CNTPLGA-fBSA conjugate facilitates RNA and transcription factor delivery. TEM was also
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used to confirm cell penetration as shown in Figure 4. 6D, where clearly there is a CNTPLGA-BSA conjugate penetrating into the cytosol, demonstrating the ability of CNTs to
transport material across the membrane. We have successfully achieved a transfection
rate higher than the 30% or 40% attained by polymers and liposome nanoparticles
indicating the promise in non-viral gene delivery vectors.

4.3.4. The efficacy of CNT-PLGA-CP3 in tuning apoptosis
Commonly used drugs for cancer therapies are alkalating agents, anti-metabolites,
plant alkaloid and terpenoids, topoisomerase inhibitors, and cytotoxic antibiotics. These
chemicals usually have side effects which not only kill cancer cells, but also induce
necrosis of normal tissue. In order to prevent the side effects, we chose caspase-3 (CP3)
as a potential candidate. CP3 is the key enzyme that is highly involved in the cell
apoptosis pathway. Apoptosis is an organized process that signals cells to self-destruct
for cell renewal or to control aberrant cell growth. Apoptosis controls the orderly death of
damaged cells, whereas necrosis occurs as a result of tissue damage, causing the loss of
both damaged and surrounding cells [280]. There are two routes for apoptosis pathway:
intrinsic and extrinsic.
Intrinsic apoptotic stimuli, such as DNA damage or endoplasmic reticulum (ER)
stress, activate B cell lymphoma 2 (BCL-2), homology 3 (BH3)-only proteins. This
activation leads activate BCL-2-associated X protein (BAX) and BCL-2 antagonist or
killer (BAK) and mitochondrial outer membrane permeabilization (MOMP). Following
MOMP, release of various proteins from the mitochondrial intermembrane space
promotes caspase activation and apoptosis. Cytochrome c binds apoptotic protease-
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activating factor 1 (APAF1), inducing its oligomerization and thereby forming a structure
termed the apoptosome that recruits and activates an initiator caspase: caspase-9.
Caspase-9 cleaves and activates executioner caspases: caspase-3 and caspase-7, leading
cells to apoptosis [281].
The extrinsic apoptotic pathway is initiated by the ligation of death receptors with
their cognate ligands, leading to the recruitment of adaptor molecules such as FASassociated death domain protein (FADD) and then caspase-8. This results in the
dimerization and activation of caspase-8, which can then directly cleave and activate
caspase-3 and caspase-7, leading to apoptosis [281]. What’s interesting here is that
caspase-3 is the downstream and key enzyme responsible in leading cells to apoptosis for
both routes. Thus we chose caspase-3 for our study in cancer therapy.
We used MTT assays to test the cell viability as a standard to measure the ability
of CNT-PLGA-CP3 to release CP3. The working concentration is set very low in order to
eliminate cell necrosis induced by large amount of CNTs. Researchers has demonstrated
that functionalized CNTs were found to be less toxic than pristine CNTs [282, 283] and
pristine CNTs in low concentrations are also able to exhibit acceptable toxicity levels
[284]. So cell death experienced in this experiment is attributed to the contribution of
CP3 delivered into cells inducing apoptosis.
Pro-Ject is commercially available liposomes for protein delivery; we use Pro-Ject
liposomes as a positive control in comparison to our CNT-PLGA-CP3 conjugation. As
shown in Figure 4. 7A, no significant differences were observed in CNT-PLGA-CP3
groups on day 1, however, Pro-Ject groups showed significant difference in comparison.
We attribute this to the fact that the degradation of PLGA hasn’t fully allowed the release
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of significant amounts of CP3 [285]. Pro-Ject liposomes released material with minimal
differences in dosage on Day 1. We hypothesize that the average amount of CP3
delivered was significant enough to induce apoptosis even at minimal concentrations.

Figure 4. 7 Cell viability on day 1 (A) and day 3 (B) of MG-63 cells under
exposure of different dosages of carbon nanoutbes, CNT-PLGA, CNT-PLGABSA, caspase-3, Pro-Ject and CNT-PLGA-CP3 treatment. * means significant
difference of cell viability under CNT-PLGA-CP3 cojugates exposure and other
groupes of same dosage. Results showed that carbon nanotubes have a great
ability to penetrate cells and release caspase-3. Our conjugation can release
caspase-3 in a week.
Interestingly, the cell viability of all Pro-Ject liposome samples average at
approximately 50%. Considering the CP3 was enough to induce apoptosis, the efficiency
of Pro-Ject liposome groups was close to 50%. Figure 4. 7B shows the cell viability of

95

CNT-PLGA-CP3 treated samples were significantly small compared to positive and
negative controls on Day 3. Pro-Ject liposome groups treated samples showed minimal
differences in this case, indicating there was little to no consistency of material delivery
over long periods. Conjugate dosage played an important role in inducing cell apoptosis
with no significant differences observed between CNT-PLGA-CP3 in low dosages and
controls while CNT-PLGA-CP3 conjugates in high concentration exhibited a
significantly low cell viability compared to other controls. We believe the amount of
transcription factor reacting with the CNT-PLGA complex is same but the amount of
CP3 released was highly dependent on the conjugate dosage.
We also conducted long-term cell viability tests at two high dosages with no
additional treatments throughout the experiment. The results shown in Figure 4. 7C and
Figure 4. 7D show that cell viability was still suppressed by treating 1 µg/ml CNTPLGA-CP3 on Day 5 and 3 µg/ml CNT-PLGA-CP3 on Day 7, respectively. Note that
cancer cells were able to recover and become fully confluent under Pro-Ject liposome
groups between Day 1 and Day 3. We believe CP3 is superior due to the gradual release
profile. To further demonstrate this point in vitro, we carried out BSA release profile in
vitro.
In order to detect the BSA release with a UV-Vis spectrometer, we increased the
amount of BSA (200 µg compared to 5 µg of caspase-3) reacting with the CNT-PLGA
complex. This increased amount of BSA resulted in BSA released at detectable levels
through UV-Vis spectrometer. A calibration curve was made to calculate the protein
concentration (Figure 4. 8). The protein loaded onto 100 µg of CNT-PLGA was
119±6.73 µg per 200 µg. We observed a gradual release of BSA through the time points
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in the 10-day trial (). Throughout the first two days we saw only a slight release of BSA
while more than 5 µg of BSA was released after Day 7. This is a possible explanation for
the CNT-PLGA-CP3 conjugates showing limited inhibitory effects on Day 1 while the
CNT-PLGA-CP3 conjugates showed significantly higher inhibitory effects after Day 3.
With only 5 µg of CP3 in the starting reaction, this may help explain the inhibitory
effects on cell growth diminishing after Day 7. We also observed an increase in BSA
released from Day 8 to Day 10. This is because the large molecular weight PLGA was
hydrolyzed to a small fraction, which leads to an increase in protein release. Due to the
fact that the CNT-PLGA-CP3 conjugates face a more complicated enzymatic
environment, it is extremely difficult to quantitatively monitor the release profile in situ.
However, this release profile data in combination with our cytotoxicity data give us
confidence in the reliability of our results.
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Figure 4. 8 Calibration curve of BSA concentration vs UV
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Figure 4. 9. BSA release fraction from the CNT-PLGABSA conjugates at predetermined time points. CNTPLGA-BSA dispersed in PBS was incubated in a water
bath (37oC).

4.4.

Conclusions
We were able to successfully fabricate a CNT-PLGA system, which is able to

deliver biological material including genes, transcriptional factors, and signal molecules
into cells. This system has shown a high transfection rate and a reliable, time dependent
release profile. Yet another advantage to this system is that the releasing profile can be
tuned simply by controlling the molecular weight and ratio of PLGA.
In determining the release profiles of the CNT-PLGA with differing PLGA to
PGA and molecular weights, we simplified the experiment using PLGA nanoparticles as
an alternative. A calibration curve was made (Figure 4. 10). We observed in general that
resveratrol was gradually released from all three groups of PLGA nanoparticles (Figure
4. 11). Note that because the resveratrol was not covalently bound to the PLGA, the
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release fraction of resveratrol is higher than that of BSA, which is covalently bound to the
CNT-PLGA complex. The amount of resveratrol loaded on to the PLGA nanoparticles
are 38%, 36%, and 40%. Interestingly, the 3 groups of PLGA nanoparticles showed
different trends of release profiles with the smaller molecular weight PLGA nanoparticles
releasing more resveratrol than the higher molecular weight counterparts. Considering the
method to covalently bind the protein to the CNT-PLGA, the conjugates would require
more time for the same fraction of BSA released.
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Figure 4. 10. Calibration curve of resveratrol concentration
versus UV absorption at 327 nm.
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Figure 4. 11 Resveratrol release fraction from the PLGA
nanoparticles. PLGA nanoparticles were made from
PLGA with differing ratios of PLA to PGA and
molecular
weight
(5,000-16,000/50:50,
16,00029,000/50:50 and 75,000-100,000/75:25). Resveratrol
was released more at the same time point by
nanoparticles made by low molecular weight PLGA.
In all aspects, this CNT-PLGA-protein conjugation is a highly efficient and
promising as drug delivery system with possible future applications in both treating
cancer and directing cellular behavior through intracellular pathways. More attractively,
despite the self-fluorescence of CNTs, fluoresce proteins can be conjugated to CNTs for
the purpose of imaging hazard distribution, drug bio distribution and disease detection.
The most innovative aspect of our conjugates is that our DDS system based on
CNT-PLGA is that we can tune the temporal release profile by controlling the molecular
weight and PGA to PLA ratio, which so far has not been established yet. By employing
this DDS system, we can incorporate a cocktail of the drugs either for cancer treatment or
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stem differentiation, and deliver this cocktail of drugs sequentially by just one shot. This
invention would help patients release at significant level.
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CHAPTER 5

Summary

CNTs for biomedical engineering has been an emerging area. CNTs are promising
candidate in tissue engineering, biomedical imaging and gene delivery. In the previous
three chapters, we demonstrated the ability of CNTs as extracellular and intracellular cues
to control cellular behaviors.
As extracellular matrix, we developed an aligned CNT substrate to align HUVEC
and culture hESCs at single cell level (Chapter2). We functionalized carboxyl CNTs with
the ligand proteins and aligned these CNT-ligand conjugates on an Au coated glass
substrate by spin coating. With this our newly developed CNT substrate, we can culture
hESCs at single cell level, and can control their migrating as demonstrated by HUVEC.
This was the great novelty in the Chapter 2. By culturing single hESC, we can take a step
forward to different single hESCs to desired phenotype with limited heterogeneity. This
would allow us for better understanding differentiation of hESC at single cell level.
We also developed a CNT containing PLGA scaffolds for bone regeneration in
Chapter 3. Mechanically strengthened CNT/PLGA scaffolds were fabricated through a
dispersion of CNT in PLGA/dichloromethane solution followed by a solvent casting and
particulate leaching step. The incorporation of CNTs allowed for tuning the mechanical
strength and nano roughness without compromising the porous architecture of scaffolds.
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Our results demonstrated that the addition of CNT to PLGA scaffolds led to a
significant increase in adhesion, growth and osteogenic differentiation of cells. We were
able to confirm the coupling of matrix stiffness and mechanical strength to enhanced
osteogenesis in 3D environment by those results. Note that previous reports have just
related only one of these two aspects to osteogenesis. Our results first demonstrated
mechanical strength and nano roughness were link to osteogenesis together. This finding
demonstrated CNTs to be a powerful tool in scaffolds design for stem cell based tissue
engineering.
As intracellular cue vesicles, a number of biological cargo has been already
delivered intracellularly by a several types of linkers such as PEG or not. We developed a
new CNT-PLGA conjugate to delivery biological cargoes into cells in Chapter 5. This
system waas able to deliver biological material including genes, transcriptional factors,
and signal molecules into cells with a high efficiency. The most innovative aspect of our
conjugates was that our DDS system based on CNT-PLGA can tune the temporal release
profile by controlling the molecular weight and PGA to PLA ratio, which so far has not
been established yet. By employing this DDS system, we can incorporate a cocktail of the
drugs either for cancer treatment or stem differentiation, and deliver this cocktail of drugs
sequentially by just one shot. This invention would help patients relieved at significant
level. More attractively, despite the self-fluorescence of CNTs, fluoresce proteins can be
conjugated to CNTs for the purpose of imaging the hazard distribution, drug bio
distribution and disease detection.

103

REFERENCE
[1] Iijima S. Helical Microtubules of Graphitic Carbon. Nature. 1991;354:56-8.
[2] Baughman RH, Zakhidov AA, de Heer WA. Carbon nanotubes - the route toward
applications. Science. 2002;297:787-92.
[3] O'Connell M. Carbon nanotubes : properties and applications. Boca Raton, FL:
CRC/Taylor & Francis; 2006.
[4] Flahaut E, Bacsa R, Peigney A, Laurent C. Gram-scale CCVD synthesis of doublewalled carbon nanotubes. Chem Commun (Camb). 2003:1442-3.
[5] Liu L, Guo GY, Jayanthi CS, Wu SY. Colossal paramagnetic moments in metallic
carbon nanotori. Phys Rev Lett. 2002;88:217206.
[6] Nasibulin AG, Pikhitsa PV, Jiang H, Brown DP, Krasheninnikov AV, Anisimov AS,
et al. A novel hybrid carbon material. Nat Nanotechnol. 2007;2:156-61.
[7] Abou-Hamad E, Kim Y, Wagberg T, Boesch D, Aloni S, Zettl A, et al. Molecular
dynamics and phase transition in one-dimensional crystal of C(60) encapsulated
inside single wall carbon nanotubes. ACS Nano. 2009;3:3878-83.
[8] Saito N, Usui Y, Aoki K, Narita N, Shimizu M, Hara K, et al. Carbon nanotubes:
biomaterial applications. Chemical Society reviews. 2009;38:1897-903.
[9] Fu CF, Gu LX. Composite Fibers from Poly(vinyl alcohol) and Poly(vinyl alcohol)Functionalized Multiwalled Carbon Nanotubes. J Appl Polym Sci. 2013;128:104453.

104

[10] Lin TC, Huang BR. Temperature effect on hydrogen response for cracked carbon
nanotube/nickel (CNT/Ni) composite film with horizontally aligned carbon
nanotubes. Sensor Actuat B-Chem. 2013;185:548-52.
[11] Wang HF, Muren NB, Ordinario D, Gorodetsky AA, Barton JK, Nuckolls C.
Transducing methyltransferase activity into electrical signals in a carbon nanotubeDNA device. Chem Sci. 2012;3:62-5.
[12] Cheon JH, Lim J, Seo SM, Woo JM, Kim SH, Kwon Y, et al. Electrical
Characteristics of the Concentric-Shape Carbon Nanotube Network Device in pH
Buffer Solution. Ieee T Electron Dev. 2010;57:2684-9.
[13] Jeong H, Gweon HM, Kwon BJ, Ahn YH, Park JY. Uncovering operational
mechanisms of a single-walled carbon nanotube network device using local probe
electrical characterizations. Nanotechnology. 2009;20.
[14] Lee J, Liao A, Pop E, King WP. Electrical and Thermal Coupling to a Single-Wall
Carbon Nanotube Device Using an Electrothermal Nanoprobe. Nano Letters.
2009;9:1356-61.
[15] Silambarasan D, Surya VJ, Vasu V, Iyakutti K. One-step process of hydrogen
storage in single walled carbon nanotubes-tin oxide nano composite. Int J
Hydrogen Energ. 2013;38:4011-6.
[16] Chen L, Xia KS, Huang LZ, Li LW, Pei LB, Fei SX. Facile synthesis and hydrogen
storage application of nitrogen-doped carbon nanotubes with bamboo-like structure.
Int J Hydrogen Energ. 2013;38:3297-303.

105

[17] Vozzi G, Corallo C, Daraio C. Pressure-activated microsyringe composite scaffold
of poly(L-lactic acid) and carbon nanotubes for bone tissue engineering. J Appl
Polym Sci. 2013;129:528-36.
[18] Liao CZ, Li K, Wong HM, Tong WY, Yeung KWK, Tjong SC. Novel
polypropylene biocomposites reinforced with carbon nanotubes and hydroxyapatite
nanorods for bone replacements. Mat Sci Eng C-Mater. 2013;33:1380-8.
[19] Cheng Q, Rutledge K, Jabbarzadeh E. Carbon nanotube-poly(lactide-co-glycolide)
composite scaffolds for bone tissue engineering applications. Ann Biomed Eng.
2013;41:904-16.
[20] Minati L, Antonini V, Dalla Serra M, Speranza G. Multifunctional Branched GoldCarbon Nanotube Hybrid for Cell Imaging and Drug Delivery. Langmuir.
2012;28:15900-6.
[21] Liu D, Wang ZG, Wang LJ, Cuschieri A. Finite Element Study of Carbon Nanotube
Induced Cell Membrane Poration for Drug and Gene Delivery. J Med Imag Health
In. 2012;2:132-8.
[22] Liu Z, Winters M, Holodniy M, Dai HJ. siRNA delivery into human T cells and
primary cells with carbon-nanotube transporters. Angew Chem Int Edit.
2007;46:2023-7.
[23] Takagi D, Homma Y, Hibino H, Suzuki S, Kobayashi Y. Single-walled carbon
nanotube growth from highly activated metal nanoparticles. Nano Letters.
2006;6:2642-5.

106

[24] Garcia-Cespedes J, Rubio-Roy M, Polo MC, Pascual E, Andujar U, Bertran E.
Carbon nanotubes grown by asymmetric bipolar pulsed-DC PECVD. Diam Relat
Mater. 2007;16:1131-5.
[25] Coleman JN, Khan U, Blau WJ, Gun'ko YK. Small but strong: A review of the
mechanical

properties

of

carbon

nanotube-polymer

composites.

Carbon.

2006;44:1624-52.
[26] Overney G, Zhong W, Tomanek D. Structural Rigidity and Low-Frequency
Vibrational-Modes of Long Carbon Tubules. Z Phys D Atom Mol Cl. 1993;27:936.
[27] Wong EW, Sheehan PE, Lieber CM. Nanobeam mechanics: Elasticity, strength, and
toughness of nanorods and nanotubes. Science. 1997;277:1971-5.
[28] Yu MF, Lourie O, Dyer MJ, Moloni K, Kelly TF, Ruoff RS. Strength and breaking
mechanism of multiwalled carbon nanotubes under tensile load. Science.
2000;287:637-40.
[29] Yu MF, Files BS, Arepalli S, Ruoff RS. Tensile loading of ropes of single wall
carbon nanotubes and their mechanical properties. Phys Rev Lett. 2000;84:5552-5.
[30] Filleter T, Bernal R, Li S, Espinosa HD. Ultrahigh Strength and Stiffness in CrossLinked Hierarchical Carbon Nanotube Bundles. Adv Mater. 2011;23:2855-+.
[31] Jiang YY, Zhou W, Kim T, Huang Y, Zuo JM. Measurement of radial deformation
of single-wall carbon nanotubes induced by intertube van der Waals forces. Phys
Rev B. 2008;77.
[32] Ruoff RS, Tersoff J, Lorents DC, Subramoney S, Chan B. Radial Deformation of
Carbon Nanotubes by Van-Der-Waals Forces. Nature. 1993;364:514-6.

107

[33] Zhao B, Hu H, Mandal SK, Haddon RC. A bone mimic based on the self-assembly
of hydroxyapatite on chemically functionalized single-walled carbon nanotubes.
Chem Mater. 2005;17:3235-41.
[34] Zanello LP, Zhao B, Hu H, Haddon RC. Bone cell proliferation on carbon
nanotubes. Nano Letters. 2006;6:562-7.
[35] Botti S. Physical properties of carbon nanotubes. Kerala, India: Transworld Research
Network; 2007.
[36] Sharma A, Tomar M, Gupta V. Room temperature trace level detection of NO2 gas
using SnO2 modified carbon nanotubes based sensor. J Mater Chem.
2012;22:23608-16.
[37] Ghaddab B, Sanchez JB, Mavon C, Paillet M, Parret R, Zahab AA, et al. Detection
of O-3 and NH3 using hybrid tin dioxide/carbon nanotubes sensors: Influence of
materials and processing on sensor's sensitivity. Sensor Actuat B-Chem.
2012;170:67-74.
[38] Vanhove L. The Occurrence of Singularities in the Elastic Frequency Distribution of
a Crystal. Phys Rev. 1953;89:1189-93.
[39] Miyauchi Y, Oba M, Maruyama S. Cross-polarized optical absorption of singlewalled nanotubes by polarized photoluminescence excitation spectroscopy. Phys
Rev B. 2006;74.
[40] Iakoubovskii K, Minami N, Kim Y, Miyashita K, Kazaoui S, Nalini B. Midgap
luminescence centers in single-wall carbon nanotubes created by ultraviolet
illumination. Appl Phys Lett. 2006;89.

108

[41] Iakoubovskii K, Minami N, Ueno T, Kazaoui S, Kataura H. Optical characterization
of double-wall carbon nanotubes: Evidence for inner tube shielding. J Phys Chem
C. 2008;112:11194-8.
[42] Kataura H, Kumazawa Y, Maniwa Y, Umezu I, Suzuki S, Ohtsuka Y, et al. Optical
properties of single-wall carbon nanotubes. Synthetic Met. 1999;103:2555-8.
[43] Miyata Y, Yanagi K, Maniwa Y, Kataura H. Optical properties of metallic and
semiconducting

single-wall

carbon

nanotubes.

Phys

Status

Solidi

B.

2008;245:2233-8.
[44] Ximenes JCM, Melo GC, Melo VMM, Mendes J, Souza AG. Optical properties of
single wall carbon nanotubes dispersed in biopolymers. J Phys Chem Solids.
2012;73:232-6.
[45] Mizuno K, Ishii J, Kishida H, Hayamizu Y, Yasuda S, Futaba DN, et al. A black
body absorber from vertically aligned single-walled carbon nanotubes. P Natl Acad
Sci USA. 2009;106:6044-7.
[46] Souza AG, Chou SG, Samsonidze GG, Dresselhaus G, Dresselhaus MS, An L, et al.
Stokes and anti-Stokes Raman spectra of small-diameter isolated carbon nanotubes.
Phys Rev B. 2004;69.
[47] Fantini C, Jorio A, Souza M, Strano MS, Dresselhaus MS, Pimenta MA. Optical
transition energies for carbon nanotubes from resonant Raman spectroscopy:
Environment and temperature effects. Phys Rev Lett. 2004;93.
[48] Thostenson ET, Li CY, Chou TW. Nanocomposites in context. Compos Sci
Technol. 2005;65:491-516.

109

[49] Sinha S, Barjami S, Iannacchione G, Schwab A, Muench G. Off-axis thermal
properties of carbon nanotube films. J Nanopart Res. 2005;7:651-7.
[50] Li SH, Feng L, Li HJ, Zhai J, Song YL, Jiang L, et al. Super-hydrophobicity of postlike aligned carbon nanotube films. Chem J Chinese U. 2003;24:340-2.
[51] Aschberger K, Johnston HJ, Stone V, Aitken RJ, Hankin SM, Peters SA, et al.
Review of carbon nanotubes toxicity and exposure--appraisal of human health risk
assessment based on open literature. Critical reviews in toxicology. 2010;40:75990.
[52] Liu Z, Tabakman S, Welsher K, Dai HJ. Carbon Nanotubes in Biology and
Medicine: In vitro and in vivo Detection, Imaging and Drug Delivery. Nano Res.
2009;2:85-120.
[53] Tournus F, Latil S, Heggie MI, Charlier JC. pi-stacking interaction between carbon
nanotubes and organic molecules. Phys Rev B. 2005;72.
[54] Petrov P, Stassin F, Pagnoulle C, Jerome R. Noncovalent functionalization of multiwalled

carbon

nanotubes

by

pyrene

containing

polymers.

Chemical

communications. 2003:2904-5.
[55] Zimmerli U, Koumoutsakos P. Simulations of electrophoretic RNA transport
through transmembrane carbon nanotubes. Biophys J. 2008;94:2546-57.
[56] Ostojic GN, Ireland JR, Hersam MC. Noncovalent functionalization of DNAwrapped single-walled carbon nanotubes with platinum-based DNA cross-linkers.
Langmuir. 2008;24:9784-9.

110

[57] Simmons TJ, Bult J, Hashim DP, Linhardt RJ, Ajayan PM. Noncovalent
functionalization as an alternative to oxidative acid treatment of single wall carbon
nanotubes with applications for polymer composites. Acs Nano. 2009;3:865-70.
[58] Xue CH, Zhou RJ, Shi MM, Gao Y, Wu G, Zhang XB, et al. The preparation of
highly water-soluble multi-walled carbon nanotubes by irreversible noncovalent
functionalization

with

a

pyrene-carrying

polymer.

Nanotechnology.

2008;19:215604.
[59] Cheng F, Adronov A. Noncovalent functionalization and solubilization of carbon
nanotubes by using a conjugated Zn-porphyrin polymer. Chemistry. 2006;12:50539.
[60] Chng EL, Pumera M. Nanographite impurities in carbon nanotubes: their influence
on the oxidation of insulin, nitric oxide, and extracellular thiols. Chemistry.
2012;18:1401-7.
[61] Yeh JM, Chang KC, Peng CW, Lai MC, Hwang SS, Lin HR, et al. Enhancement in
insulation and mechanical properties of PMMA nanocomposite foams infused with
multi-walled carbon nanotubes. J Nanosci Nanotechnol. 2011;11:6757-64.
[62] Khandare JJ, Jalota-Badhwar A, Satavalekar SD, Bhansali SG, Aher ND, Kharas F,
et al. PEG-conjugated highly dispersive multifunctional magnetic multi-walled
carbon nanotubes for cellular imaging. Nanoscale. 2012;4:837-44.
[63] Moghaddam MJ, Yang W, Bojarski B, Gengenbach TR, Gao M, Zareie H, et al.
Azide photochemistry for facile modification of graphitic surfaces: preparation of
DNA-coated carbon nanotubes for biosensing. Nanotechnology. 2012;23:425503.

111

[64] Liu C, Zhang Q, Stellacci F, Marzari N, Zheng L, Zhan Z. Carbene-functionalized
single-walled carbon nanotubes and their electrical properties. Small. 2011;7:125763.
[65] Bayazit MK, Coleman KS. Fluorescent single-walled carbon nanotubes following
the 1,3-dipolar cycloaddition of pyridinium ylides. J Am Chem Soc.
2009;131:10670-6.
[66] Lutolf MP, Hubbell JA. Synthetic biomaterials as instructive extracellular
microenvironments for morphogenesis in tissue engineering. Nat Biotechnol.
2005;23:47-55.
[67] Conrad ME, Umbreit JN. A concise review: iron absorption--the mucin-mobilferrinintegrin pathway. A competitive pathway for metal absorption. American journal of
hematology. 1993;42:67-73.
[68] Discher DE, Janmey P, Wang YL. Tissue cells feel and respond to the stiffness of
their substrate. Science. 2005;310:1139-43.
[69] Lo CM, Wang HB, Dembo M, Wang YL. Cell movement is guided by the rigidity of
the substrate. Biophys J. 2000;79:144-52.
[70] Lo CM, Wang YL. Guidance of cell movement by substrate rigidity. Mol Biol Cell.
1999;10:259a-a.
[71] Shier D, Butler J, Lewis R. Hole's human anatomy & physiology. 12th ed. Dubuque:
McGraw-Hill; 2010.
[72] Goldberg VM, Stevenson S, Feighan J, Davy D. Biology of Grit-Blasted TitaniumAlloy Implants. Clin Orthop Relat R. 1995:122-9.

112

[73] Feighan JE, Goldberg VM, Davy D, Parr JA, Stevenson S. The Influence of SurfaceBlasting on the Incorporation of Titanium-Alloy Implants in a Rabbit
Intramedullary Model. Journal of Bone and Joint Surgery-American Volume.
1995;77:1380-95.
[74] D'Lima DD, Lemperle SM, Chen PC, Holmes RE, Colwell CW, Jr. Bone response
to implant surface morphology. The Journal of arthroplasty. 1998;13:928-34.
[75] Walboomers XF, Croes HJE, Ginsel LA, Jansen JA. Contact guidance of rat
fibroblasts on various implant materials. J Biomed Mater Res. 1999;47:204-12.
[76] Lampin M, WarocquierClerout R, Legris C, Degrange M, SigotLuizard MF.
Correlation between substratum roughness and wettability, cell adhesion, and cell
migration. J Biomed Mater Res. 1997;36:99-108.
[77] D'Angelo F, Armentano I, Mattioli S, Crispoltoni L, Tiribuzi R, Cerulli GG, et al.
Micropatterned Hydrogenated Amorphous Carbon Guides Mesenchymal Stem
Cells Towards Neuronal Differentiation. Eur Cells Mater. 2010;20:231-44.
[78] Curtis A, Wilkinson C. New depths in cell behaviour: reactions of cells to
nanotopography. Biochem Soc Symp. 1999:15-26.
[79] Blaese RM. The Ada Human Gene-Therapy Clinical Protocol. Hum Gene Ther.
1990;1:327-9.
[80] Anderson WF. Human gene therapy. Nature. 1998;392:25-30.
[81] Sun YS, Finger C, Alvarez-Vallina L, Cichutek K, Buchholz CJ. Chronic gene
delivery of interferon-inducible protein 10 through replication-competent retrovirus
vectors suppresses tumor growth. Cancer Gene Ther. 2005;12:900-12.

113

[82] Hoffman RM. Noninvasive imaging for evaluation of the systemic delivery of
capsid-modified adenovirus in an orthotopic model of advanced lung cancer.
Cancer. 2007;109:1213-.
[83] Marks WJ, Ostrem JL, Verhagen L, Starr PA, Larson PS, Bakay RAE, et al. Safety
and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus
serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label,
phase I trial. Lancet Neurol. 2008;7:400-8.
[84] Yang XZ, Dou S, Sun TM, Mao CQ, Wang HX, Wang J. Systemic delivery of
siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapy. J
Control Release. 2011;156:203-11.
[85] Na K, Lee KH, Lee DH, Bae YH. Biodegradable thermo-sensitive nanoparticles
from poly(L-lactic acid)/poly(ethylene glycol) alternating multi-block copolymer
for potential anti-cancer drug carrier. Eur J Pharm Sci. 2006;27:115-22.
[86] Xu JS, Huang JW, Qin RG, Hinkle GH, Povoski SP, Martin EW, et al. Synthesizing
and binding dual-mode poly (lactic-co-glycolic acid) (PLGA) nanobubbles for
cancer targeting and imaging. Biomaterials. 2010;31:1716-22.
[87] Kim TH, Jin H, Kim HW, Cho MH, Cho CS. Mannosylated chitosan nanoparticlebased cytokine gene therapy suppressed cancer growth in BALB/c mice bearing
CT-26 carcinoma cells. Mol Cancer Ther. 2006;5:1723-32.
[88] Nicklas M, Schatton W, Heinemann S, Hanke T, Kreuter J. Preparation and
characterization of marine sponge collagen nanoparticles and employment for the
transdermal delivery of 17 beta-estradiol-hemihydrate. Drug Dev Ind Pharm.
2009;35:1035-42.

114

[89] Ge J, Min SH, Kim DM, Lee DC, Park KC, Yeom YI. Selective gene delivery to
cancer

cells

secreting

matrix

metalloproteinases

using

a

gelatin/polyethylenimine/DNA complex. Biotechnol Bioproc E. 2012;17:160-7.
[90] Bremmell KE, Tan A, Martin A, Prestidge CA. Tableting lipid-based formulations
for oral drug delivery: a case study with silica nanoparticle-lipid-mannitol hybrid
microparticles. J Pharm Sci. 2013;102:684-93.
[91] Wang G, Zheng L, Zhao H, Miao J, Sun C, Ren N, et al. In vitro assessment of the
differentiation potential of bone marrow-derived mesenchymal stem cells on
genipin-chitosan conjugation scaffold with surface hydroxyapatite nanostructure for
bone tissue engineering. Tissue engineering Part A. 2011;17:1341-9.
[92] Park JU, Meitl MA, Hur SH, Usrey ML, Strano MS, Kenis PJ, et al. In situ
deposition and patterning of single-walled carbon nanotubes by laminar flow and
controlled

flocculation

in

microfluidic

channels.

Angewandte

Chemie.

2006;45:581-5.
[93] Kamat PV, Thomas KG, Barazzouk S, Girishkumar G, Vinodgopal K, Meisel D.
Self-assembled linear bundles of single wall carbon nanotubes and their alignment
and deposition as a film in a dc field. J Am Chem Soc. 2004;126:10757-62.
[94] Jo JW, Jung JW, Lee JU, Jo WH. Fabrication of highly conductive and transparent
thin films from single-walled carbon nanotubes using a new non-ionic surfactant
via spin coating. Acs Nano. 2010;4:5382-8.
[95] Aziz MA, Yang H. Surfactant and polymer-free electrochemical micropatterning of
carboxylated multi-walled carbon nanotubes on indium tin oxide electrodes.
Chemical communications. 2008:826-8.

115

[96] Namgung S, Baik KY, Park J, Hong S. Controlling the growth and differentiation of
human mesenchymal stem cells by the arrangement of individual carbon nanotubes.
Acs Nano. 2011;5:7383-90.
[97] Abdullah CA, Asanithi P, Brunner EW, Jurewicz I, Bo C, Azad CL, et al. Aligned,
isotropic and patterned carbon nanotube substrates that control the growth and
alignment of Chinese hamster ovary cells. Nanotechnology. 2011;22:205102.
[98] Kamali R, Binesh AR. A comparison of neural networks and adaptive neuro-fuzzy
inference systems for the prediction of water diffusion through carbon nanotubes.
Microfluid Nanofluid. 2013;14:575-81.
[99] Liu Z, Chen K, Davis C, Sherlock S, Cao QZ, Chen XY, et al. Drug delivery with
carbon nanotubes for in vivo cancer treatment. Cancer Res. 2008;68:6652-60.
[100] White AA, Best SM, Kinloch IA. Hydroxyapatite-carbon nanotube composites for
biomedical applications: A review. Int J Appl Ceram Tec. 2007;4:1-13.
[101] Saito N, Usui Y, Aoki K, Narita N, Shimizu M, Ogiwara N, et al. Carbon
nanotubes for biomaterials in contact with bone. Curr Med Chem. 2008;15:523-7.
[102] Usui Y, Aoki K, Narita N, Murakami N, Nakamura I, Nakamura K, et al. Carbon
nanotubes with high bone-tissue compatibility and bone-formation acceleration
effects. Small. 2008;4:240-6.
[103] Saito N, Usui Y, Aoki K, Narita N, Shimizu M, Hara K, et al. Carbon nanotubes:
biomaterial applications. Chem Soc Rev. 2009;38:1897-903.
[104] Zinger O, Anselme K, Denzer A, Habersetzer P, Wieland M, Jeanfils J, et al. Timedependent morphology and adhesion of osteoblastic cells on titanium model
surfaces featuring scale-resolved topography. Biomaterials. 2004;25:2695-711.

116

[105] Su X, Sun K, Cui FZ, Landis WJ. Organization of apatite crystals in human woven
bone. Bone. 2003;32:150-62.
[106] Yi CQ, Liu DD, Fong CC, Zhang JC, Yang MS. Gold Nanoparticles Promote
Osteogenic Differentiation of Mesenchymal Stem Cells through p38 MAPK
Pathway. Acs Nano. 2010;4:6439-48.
[107] Kim MJ, Choi MU, Kim CW. Activation of phospholipase D1 by surface
roughness of titanium in MG63 osteoblast-like cell. Biomaterials. 2006;27:5502-11.
[108] Supronowicz PR, Ajayan PM, Ullmann KR, Arulanandam BP, Metzger DW,
Bizios R. Novel current-conducting composite substrates for exposing osteoblasts
to alternating current stimulation. J Biomed Mater Res. 2002;59:499-506.
[109] Elias KL, Price RL, Webster TJ. Enhanced functions of osteoblasts on nanometer
diameter carbon fibers. Biomaterials. 2002;23:3279-87.
[110] Bacakova L, Grausova L, Vacik J, Fraczek A, Blazewicz S, Kromka A, et al.
Improved adhesion and growth of human osteoblast-like MG 63 cells on
biomaterials modified with carbon nanoparticles. Diam Relat Mater. 2007;16:213340.
[111] Abarrategi A, Gutierrez MC, Moreno-Vicente C, Hortiguela MJ, Ramos V, LopezLacomba JL, et al. Multiwall carbon nanotube scaffolds for tissue engineering
purposes. Biomaterials. 2008;29:94-102.
[112] Shi XF, Sitharaman B, Pham QP, Liang F, Wu K, Billups WE, et al. Fabrication of
porous ultra-short single-walled carbon nanotube nanocomposite scaffolds for bone
tissue engineering. Biomaterials. 2007;28:4078-90.

117

[113] Edwards SL, Church JS, Werkmeister JA, Ramshaw JAM. Tubular micro-scale
multiwalled carbon nanotube-based scaffolds for tissue engineering. Biomaterials.
2009;30:1725-31.
[114] Olakowska E, Woszczycka-Korczynska I, Jedrzejowska-Szypulka H, LewinKowalik J. Application of nanotubes and nanofibres in nerve repair. A review.
Folia Neuropathol. 2010;48:231-7.
[115] Wu D, Pak ES, Wingard CJ, Murashov AK. Multi-walled carbon nanotubes inhibit
regenerative axon growth of dorsal root ganglia neurons of mice. Neurosci Lett.
2012;507:72-7.
[116] Mattson MP, Haddon RC, Rao AM. Molecular functionalization of carbon
nanotubes and use as substrates for neuronal growth. J Mol Neurosci. 2000;14:17582.
[117] Hu H, Ni Y, Montana V, Haddon RC, Parpura V. Chemically Functionalized
Carbon Nanotubes as Substrates for Neuronal Growth. Nano Lett. 2004;4:507-11.
[118] Hu H, Ni Y, Mandal SK, Montana V, Zhao B, Haddon RC, et al.
Polyethyleneimine functionalized single-walled carbon nanotubes as a substrate for
neuronal growth. J Phys Chem B. 2005;109:4285-9.
[119] Chao TI, Xiang S, Chen CS, Chin WC, Nelson AJ, Wang C, et al. Carbon
nanotubes promote neuron differentiation from human embryonic stem cells.
Biochem Biophys Res Commun. 2009;384:426-30.
[120] Sayes CM, Liang F, Hudson JL, Mendez J, Guo W, Beach JM, et al.
Functionalization

density dependence

of

single-walled

cytotoxicity in vitro. Toxicol Lett. 2006;161:135-42.

118

carbon

nanotubes

[121] Zhao B, Hu H, Niyogi S, Itkis ME, Hamon MA, Bhowmik P, et al.
Chromatographic purification and properties of soluble single-walled carbon
nanotubes. J Am Chem Soc. 2001;123:11673-7.
[122] Niyogi S, Hamon MA, Hu H, Zhao B, Bhowmik P, Sen R, et al. Chemistry of
single-walled carbon nanotubes. Acc Chem Res. 2002;35:1105-13.
[123] Peer D, Karp JM, Hong S, FaroKHzad OC, Margalit R, Langer R. Nanocarriers as
an emerging platform for cancer therapy. Nat Nanotechnol. 2007;2:751-60.
[124] Heller DA, Baik S, Eurell TE, Strano MS. Single-walled carbon nanotube
spectroscopy in live cells: Towards long-term labels and optical sensors. Adv
Mater. 2005;17:2793-+.
[125] Hilder TA, Hill JM. Probability of encapsulation of paclitaxel and doxorubicin into
carbon nanotubes. Micro Nano Lett. 2008;3:41-9.
[126] Kumar A, Jena PK, Behera S, Lockey RF, Mohapatra S. Efficient DNA and
Peptide Delivery by Functionalized Chitosan-Coated Single-Wall Carbon
Nanotubes. J Biomed Nanotechnol. 2005;1:392-6.
[127] Weng XX, Wang MY, Ge J, Yu SN, Liu BH, Zhong J, et al. Carbon nanotubes as a
protein toxin transporter for selective HER2-positive breast cancer cell destruction.
Mol Biosyst. 2009;5:1224-31.
[128] Pantarotto D, Singh R, McCarthy D, Erhardt M, Briand JP, Prato M, et al.
Functionalized carbon nanotubes for plasmid DNA gene delivery. Angew Chem Int
Edit. 2004;43:5242-6.
[129] Singh R, Pantarotto D, McCarthy D, Chaloin O, Hoebeke J, Partidos CD, et al.
Binding and condensation of plasmid DNA onto functionalized carbon nanotubes:

119

Toward the construction of nanotube-based gene delivery vectors. J Am Chem Soc.
2005;127:4388-96.
[130] Ladeira MS, Andrade VA, Gomes ERM, Aguiar CJ, Moraes ER, Soares JS, et al.
Highly efficient siRNA delivery system into human and murine cells using singlewall carbon nanotubes. Nanotechnology. 2010;21.
[131] Jin H, Heller DA, Strano MS. Single-particle tracking of endocytosis and
exocytosis of single-walled carbon nanotubes in NIH-3T3 cells. Nano Letters.
2008;8:1577-85.
[132] Liu Z, Fan AC, Rakhra K, Sherlock S, Goodwin A, Chen X, et al. Supramolecular
stacking of doxorubicin on carbon nanotubes for in vivo cancer therapy.
Angewandte Chemie. 2009;48:7668-72.
[133] Liu Z, Chen K, Davis C, Sherlock S, Cao Q, Chen X, et al. Drug delivery with
carbon nanotubes for in vivo cancer treatment. Cancer Res. 2008;68:6652-60.
[134] Liu Z, Winters M, Holodniy M, Dai H. siRNA delivery into human T cells and
primary

cells

with

carbon-nanotube

transporters.

Angewandte

Chemie.

2007;46:2023-7.
[135] Antaris AL, Robinson JT, Yaghi OK, Hong GS, Diao S, Luong R, et al. Ultra-Low
Doses of Chirality Sorted (6,5) Carbon Nanotubes for Simultaneous Tumor
Imaging and Photothermal Therapy. Acs Nano. 2013;7:3644-52.
[136] Robinson JT, Hong GS, Liang YY, Zhang B, Yaghi OK, Dai HJ. In Vivo
Fluorescence Imaging in the Second Near-Infrared Window with Long Circulating
Carbon Nanotubes Capable of Ultrahigh Tumor Uptake. J Am Chem Soc.
2012;134:10664-9.

120

[137] Alidori S, Zeglis BM, Scheinberg DA, Lewis JS, McDevitt MR. Carbon nanotubes
constructs as drug delivery systems for tumor targeting and imaging. J Labelled
Compd Rad. 2011;54:S61-S.
[138] Ruggiero A, Villa CH, Holland JP, Sprinkle SR, May C, Lewis JS, et al. Imaging
and treating tumor vasculature with targeted radiolabeled carbon nanotubes. Int J
Nanomed. 2010;5:783-802.
[139] Shi XY, Wang SH, Shen MW. Tumor targeting and imaging using multifunctional
dendrimer-modified multiwalled carbon nanotubes. Abstr Pap Am Chem S.
2009;237.
[140] Xiang LZ, Yuan Y, Xing D, Ou ZM, Yang SH, Zhou FF. Photoacoustic molecular
imaging with antibody-functionalized single-walled carbon nanotubes for early
diagnosis of tumor. J Biomed Opt. 2009;14.
[141] Aschberger K, Johnston HJ, Stone V, Aitken RJ, Hankin SM, Peters SAK, et al.
Review of carbon nanotubes toxicity and exposure-Appraisal of human health risk
assessment based on open literature. Crit Rev Toxicol. 2010;40:759-90.
[142] Johnston HJ, Hutchison GR, Christensen FM, Peters S, Hankin S, Aschberger K, et
al. A critical review of the biological mechanisms underlying the in vivo and in
vitro toxicity of carbon nanotubes: The contribution of physico-chemical
characteristics. Nanotoxicology. 2010;4:207-46.
[143] Ding L, Stilwell J, Zhang T, Elboudwarej O, Jiang H, Selegue JP, et al. Molecular
characterization of the cytotoxic mechanism of multiwall carbon nanotubes and
nano-onions on human skin fibroblast. Nano Lett. 2005;5:2448-64.

121

[144] Liu D, Yi C, Zhang D, Zhang J, Yang M. Inhibition of proliferation and
differentiation of mesenchymal stem cells by carboxylated carbon nanotubes. Acs
Nano. 2010;4:2185-95.
[145] Sun Z, Liu Z, Meng J, Meng J, Duan J, Xie S, et al. Carbon nanotubes enhance
cytotoxicity mediated by human lymphocytes in vitro. Plos One. 2011;6:e21073.
[146] Poland CA, Duffin R, Kinloch I, Maynard A, Wallace WA, Seaton A, et al. Carbon
nanotubes introduced into the abdominal cavity of mice show asbestos-like
pathogenicity in a pilot study. Nat Nanotechnol. 2008;3:423-8.
[147] Lutolf MP, Gilbert PM, Blau HM. Designing materials to direct stem-cell fate.
Nature. 2009;462:433-41.
[148] Song W, Lu HX, Kawazoe N, Chen GP. Adipogenic Differentiation of Individual
Mesenchymal Stem Cell on Different Geometric Micropatterns. Langmuir.
2011;27:6155-62.
[149] Chen CS, Alonso JL, Ostuni E, Whitesides GM, Ingber DE. Cell shape provides
global control of focal adhesion assembly. Biochem Bioph Res Co. 2003;307:35561.
[150] McBeath R, Pirone DM, Nelson CM, Bhadriraju K, Chen CS. Cell shape,
cytoskeletal tension, and RhoA regulate stem cell lineage commitment.
Developmental cell. 2004;6:483-95.
[151] Zhu BS, Lu QH, Yin J, Hu J, Wang ZG. Alignment of osteoblast-like cells and
cell-produced collagen matrix induced by nanogrooves. Tissue Eng. 2005;11:82534.

122

[152] Chen CS, Tan J, Tien J. Mechanotransduction at cell-matrix and cell-cell contacts.
Annu Rev Biomed Eng. 2004;6:275-302.
[153] Sridharan I, Kim T, Wang R. Adapting collagen/CNT matrix in directing hESC
differentiation. Biochem Bioph Res Co. 2009;381:508-12.
[154] Jones ENB, Mallapragada SK. Directed growth and differentiation of stem cells
towards neural cell fates using soluble and surface-mediated cues. J Biomat SciPolym E. 2007;18:999-1015.
[155] Engler AJ, Sen S, Sweeney HL, Discher DE. Matrix elasticity directs stem cell
lineage specification. Cell. 2006;126:677-89.
[156] Forte G, Carotenuro F, Pagliari F, Pagliari S, Cossa P, Fiaccavento R, et al.
Criticality of the biological and physical stimuli array inducing resident cardiac
stem cell determination. Stem Cells. 2008;26:2093-103.
[157] Otero JJ, Fu WM, Kan LX, Cuadra AE, Kessler JA. beta-catenin signaling is
required for neural differentiation of embryonic stem cells. Development.
2004;131:3545-57.
[158] Thomas CH, Collier JH, Sfeir CS, Healy KE. Engineering gene expression and
protein synthesis by modulation of nuclear shape. P Natl Acad Sci USA.
2002;99:1972-7.
[159] Lee MR, Kwon KW, Jung H, Kim HN, Suh KY, Kim K, et al. Direct
differentiation of human embryonic stem cells into selective neurons on nanoscale
ridge/groove pattern arrays. Biomaterials. 2010;31:4360-6.

123

[160] Xie JW, Willerth SM, Li XR, Macewan MR, Rader A, Sakiyama-Elbert SE, et al.
The differentiation of embryonic stem cells seeded on electrospun nanofibers into
neural lineages. Biomaterials. 2009;30:354-62.
[161] Lee LH, Peerani R, Ungrin M, Joshi C, Kumacheva E, Zandstra PW.
Micropatterning of human embryonic stem cells dissects the mesoderm and
endoderm lineages. Stem Cell Res. 2009;2:155-62.
[162] Dai HJ, Wong EW, Lieber CM. Probing electrical transport in nanomaterials:
Conductivity of individual carbon nanotubes. Science. 1996;272:523-6.
[163] Shokrieh MM, Rafiee R. A review of the mechanical properties of isolated carbon
nanotubes and carbon nanotube composites. Mech Compos Mater. 2010;46:155-72.
[164] Cheng Q, Rutledge K, Jabbarzadeh E. Carbon Nanotube–Poly(lactide-co-glycolide)
Composite Scaffolds for Bone Tissue Engineering Applications. Ann Biomed Eng.
2013.
[165] Ishii M, Hamilton B, Poolton N. Imaging of charge trapping in distorted carbon
nanotubes by x-ray excited scanning probe microscopy. J Appl Phys. 2008;104.
[166] Borka D, Lukic V, Timko J, Jovanovic VB. Using proton beams as a diagnostic
tool in carbon nanotubes. Nucl Instrum Meth B. 2012;279:169-72.
[167] Ryoo SR, Kim YK, Kim MH, Min DH. Behaviors of NIH-3T3 Fibroblasts on
Graphene/Carbon Nanotubes: Proliferation, Focal Adhesion, and Gene Transfection
Studies. ACS Nano. 2010;4:6587-98.
[168] Zhang XK, Wang XF, Lu QH, Fu CL. Influence of carbon nanotube scaffolds on
human cervical carcinoma HeLa cell viability and focal adhesion kinase expression.
Carbon. 2008;46:453-60.

124

[169] Cheng Q, Rutledge K, Jabbarzadeh E. Carbon Nanotube-Poly(lactide-co-glycolide)
Composite Scaffolds for Bone Tissue Engineering Applications. Ann Biomed Eng.
2013.
[170] McCarron PA, Marouf WM, Donnelly RF, Scott C. Enhanced surface attachment
of protein-type targeting ligands to poly(lactide-co-glycolide) nanoparticles using
variable expression of polymeric acid functionality. J Biomed Mater Res A.
2008;87A:873-84.
[171] Liu Z, Tabakman SM, Chen Z, Dai HJ. Preparation of carbon nanotube
bioconjugates for biomedical applications. Nat Protoc. 2009;4:1372-82.
[172] Saha K, Mei Y, Reisterer CM, Pyzocha NK, Yang J, Muffat J, et al. Surfaceengineered substrates for improved human pluripotent stem cell culture under fully
defined conditions. P Natl Acad Sci USA. 2011;108:18714-9.
[173] Gunawan RC, Silvestre J, Gaskins HR, Kenis PJA, Leckband DE. Cell migration
and polarity on microfabricated gradients of extracellular matrix proteins.
Langmuir. 2006;22:4250-8.
[174] Lagunas A, Comelles J, Martinez E, Prats-Alfonso E, Acosta GA, Albericio F, et
al. Cell adhesion and focal contact formation on linear RGD molecular gradients:
study of non-linear concentration dependence effects. Nanomed-Nanotechnol.
2012;8:432-9.
[175] Rosca ID, Watari F, Uo M, Akaska T. Oxidation of multiwalled carbon nanotubes
by nitric acid. Carbon. 2005;43:3124-31.
[176] Niyogi S, Hamon MA, Hu H, Zhao B, Bhowmik P, Sen R, et al. Chemistry of
single-walled carbon nanotubes. Accounts Chem Res. 2002;35:1105-13.

125

[177] Zhao B, Hu H, Yu AP, Perea D, Haddon RC. Synthesis and characterization of
water soluble single-walled carbon nanotube graft copolymers. J Am Chem Soc.
2005;127:8197-203.
[178] Chen Z, Tabakman SM, Goodwin AP, Kattah MG, Daranciang D, Wang XR, et al.
Protein microarrays with carbon nanotubes as multicolor Raman labels. Nat
Biotechnol. 2008;26:1285-92.
[179] Liu Z, Fan AC, Rakhra K, Sherlock S, Goodwin A, Chen XY, et al.
Supramolecular Stacking of Doxorubicin on Carbon Nanotubes for In Vivo Cancer
Therapy. Angew Chem Int Edit. 2009;48:7668-72.
[180] Chen J, Liu HY, Weimer WA, Halls MD, Waldeck DH, Walker GC. Noncovalent
engineering of carbon nanotube surfaces by rigid, functional conjugated polymers.
J Am Chem Soc. 2002;124:9034-5.
[181] Moon HK, Il Chang C, Lee DK, Choi HC. Effect of Nucleases on the Cellular
Internalization of Fluorescent Labeled DNA-Functionalized Single-Walled Carbon
Nanotubes. Nano Res. 2008;1:351-60.
[182] Fournier RL. Basic transport phenomena in biomedical engineering. 2nd ed. New
York: Taylor & Francis; 2007.
[183] Chen JY, Chen SY, Zhao XR, Kuznetsova LV, Wong SS, Ojima I. Functionalized
Single-Walled Carbon Nanotubes as Rationally Designed Vehicles for TumorTargeted Drug Delivery. J Am Chem Soc. 2008;130:16778-85.
[184] Wang JX, Ye R, Wei YH, Wang HH, Xu XJ, Zhang F, et al. The effects of
electrospun TSF nanofiber diameter and alignment on neuronal differentiation of
human embryonic stem cells. J Biomed Mater Res A. 2012;100A:632-45.

126

[185] Guan JJ, Wang F, Li ZQ, Chen J, Guo XL, Liao J, et al. The stimulation of the
cardiac differentiation of mesenchymal stem cells in tissue constructs that mimic
myocardium structure and biomechanics. Biomaterials. 2011;32:5568-80.
[186] Pijnappels DA, Schalij MJ, Ramkisoensing AA, van Tuyn J, de Vries AAF, van der
Laarse A, et al. Forced alignment of mesenchymal stem cells undergoing
cardiomyogenic differentiation affects functional integration with cardiomyocyte
cultures. Circ Res. 2008;103:167-76.
[187] Wang PY, Yu JS, Lin JH, Tsai WB. Modulation of alignment, elongation and
contraction of cardiomyocytes through a combination of nanotopography and
rigidity of substrates. Acta Biomater. 2011;7:3285-93.
[188] Huang CY, Fu XL, Liu J, Qi YM, Li SH, Wang HJ. The involvement of integrin
beta 1 signaling in the migration and myofibroblastic differentiation of skin
fibroblasts

on

anisotropic

collagen-containing

nanofibers.

Biomaterials.

2012;33:1791-800.
[189] Ng CP, Swartz MA. Mechanisms of interstitial flow-induced remodeling of
fibroblast-collagen cultures. Ann Biomed Eng. 2006;34:446-54.
[190] Curran JM, Stokes R, Irvine E, Graham D, Amro NA, Sanedrin RG, et al.
Introducing dip pen nanolithography as a tool for controlling stem cell behaviour:
unlocking the potential of the next generation of smart materials in regenerative
medicine. Lab Chip. 2010;10:1662-70.
[191] You MH, Kwak MK, Kim DH, Kim K, Levchenko A, Kim DY, et al.
Synergistically Enhanced Osteogenic Differentiation of Human Mesenchymal Stem

127

Cells

by

Culture

on

Nanostructured

Surfaces

with

Induction

Media.

Biomacromolecules. 2010;11:1856-62.
[192] Dror Y, Salalha W, Khalfin RL, Cohen Y, Yarin AL, Zussman E. Carbon
nanotubes embedded in oriented polymer nanofibers by electrospinning. Langmuir.
2003;19:7012-20.
[193] Opatkiewicz J, LeMieux MC, Bao ZN. Nanotubes on Display: How Carbon
Nanotubes Can Be Integrated into Electronic Displays. ACS Nano. 2010;4:2975-8.
[194] Lin DW, Bettinger CJ, Ferreira JP, Wang CL, Bao ZN. A Cell-Compatible
Conductive Film from a Carbon Nanotube Network Adsorbed on Poly-L-lysine.
ACS Nano. 2011;5:10026-32.
[195] Chen CS, Mrksich M, Huang S, Whitesides GM, Ingber DE. Geometric control of
cell life and death. Science. 1997;276:1425-8.
[196] Burdick JA, Vunjak-Novakovic G. Engineered microenvironments for controlled
stem cell differentiation. Tissue Eng Part A. 2009;15:205-19.
[197] Kingham EJ, Tsimbouri M, Gadegaard N, Dalby MJ, Oreffo ROC.
Nanotopography induced osteogenic differentiation of human stem cells. Bone.
2011;48:S108-S9.
[198] Vartanian KB, Kirkpatrick SJ, Hanson SR, Hinds MT. Endothelial cell cytoskeletal
alignment independent of fluid shear stress on micropatterned surfaces. Biochem
Bioph Res Co. 2008;371:787-92.
[199] Gruschwitz R, Friedrichs J, Valtink M, Franz CM, Muller DJ, Funk RHW, et al.
Alignment and Cell-Matrix Interactions of Human Corneal Endothelial Cells on

128

Nanostructured Collagen Type I Matrices. Investigative ophthalmology & visual
science. 2010;51:6303-10.
[200] Namgung S, Baik KY, Park J, Hong S. Controlling the Growth and Differentiation
of Human Mesenchymal Stem Cells by the Arrangement of Individual Carbon
Nanotubes. Acs Nano. 2011;5:7383-90.
[201] Wang JHC, Goldschmidt-Clermont P, Wille J, Yin FCP. Specificity of endothelial
cell reorientation in response to cyclic mechanical stretching. J Biomech.
2001;34:1563-72.
[202] Butcher JT, Penrod AM, Garcia AJ, Nerem RM. Unique morphology and focal
adhesion development of valvular endothelial cells in static and fluid flow
environments. Arterioscl Throm Vas. 2004;24:1429-34.
[203] Uttayarat P, Chen M, Li M, Allen FD, Composto RJ, Lelkes PI. Microtopography
and flow modulate the direction of endothelial cell migration. Am J Physiol-Heart
C. 2008;294:H1027-H35.
[204] Goldfinger LE, Tzima E, Stockton R, Kiosses WB, Kinbara K, Tkachenko E, et al.
Localized alpha 4 integrin phosphorylation directs shear stress-induced endothelial
cell alignment. Circ Res. 2008;103:177-85.
[205] Cai KY, Dong HD, Chen C, Yang L, Jandt KD, Deng LH. Inkjet printing of
laminin gradient to investigate endothelial cellular alignment. Colloid Surface B.
2009;72:230-5.
[206] Lai ES, Huang NF, Cooke JP, Fuller GG. Aligned nanofibrillar collagen regulates
endothelial organization and migration. Regen Med. 2012;7:649-61.

129

[207] Uttayarat P, Perets A, Li MY, Pimton P, Stachelek SJ, Alferiev I, et al.
Micropatterning of three-dimensional electrospun polyurethane vascular grafts.
Acta Biomater. 2010;6:4229-37.
[208] Schimmenti LA, Yan HC, Madri JA, Albelda SM. Platelet endothelial cell adhesion
molecule, PECAM-1, modulates cell migration. J Cell Physiol. 1992;153:417-28.
[209] Xu CH, Inokuma MS, Denham J, Golds K, Kundu P, Gold JD, et al. Feeder-free
growth of undifferentiated human embryonic stem cells. Nat Biotechnol.
2001;19:971-4.
[210] Sjogren-Jansson E, Zetterstrom M, Moya K, Lindqvist J, Strehl R, Eriksson PS.
Large-scale propagation of four undifferentiated human embryonic stem cell lines
in a feeder-free culture system. Dev Dynam. 2005;233:1304-14.
[211] Cowan CA, Klimanskaya I, McMahon J, Atienza J, Witmyer J, Zucker JP, et al.
Derivation of embryonic stem-cell lines from human blastocysts. New Engl J Med.
2004;350:1353-6.
[212] Rosler ES, Fisk GJ, Ares X, Irving J, Miura T, Rao MS, et al. Long-term culture of
human embryonic stem cells in feeder-free conditions. Dev Dynam. 2004;229:25974.
[213] Carpenter MK, Rosler ES, Fisk GJ, Brandenberger R, Ares X, Miura T, et al.
Properties of four human embryonic stem cell lines maintained in a feeder-free
culture system. Dev Dynam. 2004;229:243-58.
[214] Hasegawa K, Fujioka T, Nakamura Y, Nakatsuji N, Suemori H. A method for the
selection of human embryonic stem cell sublines with high replating efficiency
after single-cell dissociation. Stem cells. 2006;24:2649-60.

130

[215] Draper JS, Smith K, Gokhale P, Moore HD, Maltby E, Johnson J, et al. Recurrent
gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat
Biotechnol. 2004;22:53-4.
[216] Herszfeld D, Wolvetang E, Langton-Bunker E, Chung TL, Filipczyk AA,
Houssami S, et al. CD30 is a survival factor and a biomarker for transformed
human pluripotent stem cells. Nat Biotechnol. 2006;24:351-7.
[217] Burridge PW, Thompson S, Millrod MA, Weinberg S, Yuan XA, Peters A, et al. A
Universal System for Highly Efficient Cardiac Differentiation of Human Induced
Pluripotent Stem Cells That Eliminates Interline Variability. PLoS One. 2011;6.
[218] Hudson J, Titmarsh D, Hidalgo A, Wolvetang E, Cooper-White J. Primitive
Cardiac Cells from Human Embryonic Stem Cells. Stem Cells Dev. 2012;21:151323.
[219] Laurencin CT, Ambrosio AMA, Borden MD, Cooper JA. Tissue engineering:
Orthopedic applications. Annual Review of Biomedical Engineering. 1999;1:19-46.
[220] Kessler P, Thorwarth M, Bloch-Birkholz A, Nkenke E, Neukam FW. Harvesting of
bone from the iliac crest--comparison of the anterior and posterior sites. Br J Oral
Maxillofac Surg. 2005;43:51-6.
[221] Silber JS, Anderson DG, Daffner SD, Brislin BT, Leland JM, Hilibrand AS, et al.
Donor site morbidity after anterior iliac crest bone harvest for single-level anterior
cervical discectomy and fusion. Spine (Phila Pa 1976). 2003;28:134-9.
[222] Zimmermann CE, Borner BI, Hasse A, Sieg P. Donor site morbidity after
microvascular fibula transfer. Clin Oral Investig. 2001;5:214-9.

131

[223] Nakajima T, Iizuka H, Tsutsumi S, Kayakabe M, Takagishi K. Evaluation of
posterolateral spinal fusion using mesenchymal stem cells: differences with or
without osteogenic differentiation. Spine (Phila Pa 1976). 2007;32:2432-6.
[224] Kretlow JD, Mikos AG. Review: mineralization of synthetic polymer scaffolds for
bone tissue engineering. Tissue Eng. 2007;13:927-38.
[225] Langer R, Tirrell DA. Designing materials for biology and medicine. Nature.
2004;428:487-92.
[226] Jadlowiec JA, Celil AB, Hollinger JO. Bone tissue engineering: recent advances
and promising therapeutic agents. Expert Opin Biol Ther. 2003;3:409-23.
[227] Murphy WL, Mooney DJ. Molecular-scale biomimicry. Nat Biotechnol.
2002;20:30-1.
[228] Karageorgiou V, Kaplan D. Porosity of 3D biomaterial scaffolds and osteogenesis.
Biomaterials. 2005;26:5474-91.
[229] Gloria A, De Santis R, Ambrosio L. Polymer-based composite scaffolds for tissue
engineering. J Appl Biomater Biomech.8:57-67.
[230] Rezwan K, Chen QZ, Blaker JJ, Boccaccini AR. Biodegradable and bioactive
porous polymer/inorganic composite scaffolds for bone tissue engineering.
Biomaterials. 2006;27:3413-31.
[231] Liu X, Ma PX. Polymeric scaffolds for bone tissue engineering. Ann Biomed Eng.
2004;32:477-86.
[232] Schliephake H, Weich HA, Dullin C, Gruber R, Frahse S. Mandibular bone repair
by implantation of rhBMP-2 in a slow release carrier of polylactic acid--an
experimental study in rats. Biomaterials. 2008;29:103-10.

132

[233] Larsson S, Bauer TW. Use of injectable calcium phosphate cement for fracture
fixation: a review. Clin Orthop Relat Res. 2002:23-32.
[234] Balasundaram G, Sato M, Webster TJ. Using hydroxyapatite nanoparticles and
decreased crystallinity to promote osteoblast adhesion similar to functionalizing
with RGD. Biomaterials. 2006;27:2798-805.
[235] Habraken WJ, Wolke JG, Mikos AG, Jansen JA. Injectable PLGA
microsphere/calcium phosphate cements: physical properties and degradation
characteristics. J Biomater Sci Polym Ed. 2006;17:1057-74.
[236] Khan YM, Katti DS, Laurencin CT. Novel polymer-synthesized ceramic
composite-based system for bone repair: an in vitro evaluation. J Biomed Mater
Res A. 2004;69:728-37.
[237] Saito E, Kang H, Taboas JM, Diggs A, Flanagan CL, Hollister SJ. Experimental
and computational characterization of designed and fabricated 50:50 PLGA porous
scaffolds for human trabecular bone applications. J Mater Sci Mater Med.21:237183.
[238] Spalazzi JP, Dagher E, Doty SB, Guo XE, Rodeo SA, Lu HH. In vivo evaluation of
a multiphased scaffold designed for orthopaedic interface tissue engineering and
soft tissue-to-bone integration. J Biomed Mater Res A. 2008;86:1-12.
[239] Webster TJ, Ejiofor JU. Increased osteoblast adhesion on nanophase metals: Ti,
Ti6Al4V, and CoCrMo. Biomaterials. 2004;25:4731-9.
[240] Boyan BD, Hummert TW, Dean DD, Schwartz Z. Role of material surfaces in
regulating bone and cartilage cell response. Biomaterials. 1996;17:137-46.

133

[241] Khang D, Choi J, Im YM, Kim YJ, Jang JH, Kang SS, et al. Role of subnano-,
nano- and submicron-surface features on osteoblast differentiation of bone marrow
mesenchymal stem cells. Biomaterials. 2012;33:5997-6007.
[242] Akasaka T, Yokoyama A, Matsuoka M, Hashimoto T, Watari F. Thin films of
single-walled carbon nanotubes promote human osteoblastic cells (Saos-2)
proliferation in low serum concentrations. Mat Sci Eng C-Mater. 2010;30:391-9.
[243] Rho JY, Kuhn-Spearing L, Zioupos P. Mechanical properties and the hierarchical
structure of bone. Med Eng Phys. 1998;20:92-102.
[244] Tseng IH, Lin HC, Tsai MH, Chen DS. Thermal conductivity and morphology of
silver-filled multiwalled carbon nanotubes/polyimide nanocomposite films. J Appl
Polym Sci. 2012;126:E182-E7.
[245] Kim SS, Sun Park M, Jeon O, Yong Choi C, Kim BS. Poly(lactide-coglycolide)/hydroxyapatite composite scaffolds for bone tissue engineering.
Biomaterials. 2006;27:1399-409.
[246] Wick P, Manser P, Limbach LK, Dettlaff-Weglikowska U, Krumeich F, Roth S, et
al. The degree and kind of agglomeration affect carbon nanotube cytotoxicity.
Toxicol Lett. 2007;168:121-31.
[247] Narimissa E, Gupta R, Bhaskaran M, Sriram S. Influence of nano-graphite platelet
concentration on onset of crystalline degradation in polylactide composites. Polym
Degrad Stabil. 2012;97:829-32.
[248] Saotome T, Kokubo K, Shirakawa S, Oshima T, Hahn HT. Polymer
nanocomposites reinforced with C-60 fullerene: effect of hydroxylation. J Compos
Mater. 2011;45:2595-601.

134

[249] McNally T, Potschke P, Halley P, Murphy M, Martin D, Bell SEJ, et al.
Polyethylene multiwalled carbon nanotube composites. Polymer. 2005;46:8222-32.
[250] Bikiaris D. Microstructure and Properties of Polypropylene/Carbon Nanotube
Nanocomposites. Materials. 2010;3:2884-946.
[251] Pooyan P, Tannenbaum R, Garmestani H. Mechanical behavior of a cellulosereinforced scaffold in vascular tissue engineering. J Mech Behav Biomed Mater.
2012;7:50-9.
[252] Favier V, Canova GR, Shrivastava SC, Cavaille JY. Mechanical percolation in
cellulose whisker nanocomposites. Polym Eng Sci. 1997;37:1732-9.
[253] Donaldson K, Stone V, Tran CL, Kreyling W, Borm PJA. Nanotoxicology. Occup
Environ Med. 2004;61:727-8.
[254] Donaldson K, Aitken R, Tran L, Stone V, Duffin R, Forrest G, et al. Carbon
nanotubes: a review of their properties in relation to pulmonary toxicology and
workplace safety. Toxicological sciences : an official journal of the Society of
Toxicology. 2006;92:5-22.
[255] Jensen AW, Wilson SR, Schuster DI. Biological applications of fullerenes.
Bioorganic & medicinal chemistry. 1996;4:767-79.
[256] Mikael PE, Nukavarapu SP. Functionalized Carbon Nanotube Composite Scaffolds
for Bone Tissue Engineering: Prospects and Progress. Journal of Biomaterials and
Tissue Engineering. 2011;1:76-85.
[257] Singh R, Pantarotto D, Lacerda L, Pastorin G, Klumpp C, Prato M, et al. Tissue
biodistribution and blood clearance rates of intravenously administered carbon
nanotube radiotracers. Proc Natl Acad Sci U S A. 2006;103:3357-62.

135

[258] Meng SY, Zhang Z, Rouabhia M. Accelerated osteoblast mineralization on a
conductive substrate by multiple electrical stimulation. J Bone Miner Metab.
2011;29:535-44.
[259] Martinelli V, Cellot G, Toma FM, Long CS, Caldwell JH, Zentilin L, et al. Carbon
Nanotubes Promote Growth and Spontaneous Electrical Activity in Cultured
Cardiac Myocytes. Nano Letters. 2012;12:1831-8.
[260] Stewart BW, Kleihues P, International Agency for Research on Cancer. World
cancer report. Lyon: IARC Press; 2003.
[261] Matsumura Y, Maeda H. A New Concept for Macromolecular Therapeutics in
Cancer-Chemotherapy - Mechanism of Tumoritropic Accumulation of Proteins and
the Antitumor Agent Smancs. Cancer Res. 1986;46:6387-92.
[262] Gul-Uludag H, Xu P, Marquez-Curtis LA, Xing J, Janowska-Wieczorek A, Chen J.
Cationic

liposome-mediated

CXCR4

gene

delivery

into

hematopoietic

stem/progenitor cells: implications for clinical transplantation and gene therapy.
Stem Cells Dev. 2012;21:1587-96.
[263] Kim SK, Day RW, Cahoon JF, Kempa TJ, Song KD, Park HG, et al. Tuning Light
Absorption in Core/Shell Silicon Nanowire Photovoltaic Devices through
Morphological Design. Nano Lett. 2012;12:4971-6.
[264] Goldberger J, He R, Zhang Y, Lee S, Yan H, Choi HJ, et al. Single-crystal gallium
nitride nanotubes. Nature. 2003;422:599-602.
[265] Chopra NG, Luyken RJ, Cherrey K, Crespi VH, Cohen ML, Louie SG, et al.
Boron-Nitride Nanotubes. Science. 1995;269:966-7.

136

[266] Mor GK, Varghese OK, Paulose M, Shankar K, Grimes CA. A review on highly
ordered, vertically oriented TiO2 nanotube arrays: Fabrication, material properties,
and solar energy applications. Sol Energ Mat Sol C. 2006;90:2011-75.
[267] Wang ZL. Zinc oxide nanostructures: growth, properties and applications. J PhysCondens Mat. 2004;16:R829-R58.
[268] Iijima S, Ichihashi T. Single-Shell Carbon Nanotubes of 1-Nm Diameter. Nature.
1993;363:603-5.
[269] Singh R, Pantarotto D, McCarthy D, Chaloin O, Hoebeke J, Partidos CD, et al.
Binding and condensation of plasmid DNA onto functionalized carbon nanotubes:
toward the construction of nanotube-based gene delivery vectors. J Am Chem Soc.
2005;127:4388-96.
[270] Liu Y, Yu ZL, Zhang YM, Guo DS, Liu YP. Supramolecular architectures of betacyclodextrin-modified chitosan and pyrene derivatives mediated by carbon
nanotubes and their DNA condensation. J Am Chem Soc. 2008;130:10431-9.
[271] Zheng M, Jagota A, Semke ED, Diner BA, Mclean RS, Lustig SR, et al. DNAassisted dispersion and separation of carbon nanotubes. Nat Mater. 2003;2:338-42.
[272] Cheng FY, Su CH, Wu PC, Yeh CS. Multifunctional polymeric nanoparticles for
combined chemotherapeutic and near-infrared photothermal cancer therapy in vitro
and in vivo. Chemical communications. 2010;46:3167-9.
[273] Wu Y, Phillips JA, Liu H, Yang R, Tan W. Carbon nanotubes protect DNA strands
during cellular delivery. Acs Nano. 2008;2:2023-8.
[274] Zhang ZH, Yang XY, Zhang Y, Zeng B, Wang ZJ, Zhu TH, et al. Delivery of
telomerase reverse transcriptase small interfering RNA in complex with positively

137

charged single-walled carbon nanotubes suppresses tumor growth. Clin Cancer Res.
2006;12:4933-9.
[275] Karajanagi SS, Yang HC, Asuri P, Sellitto E, Dordick JS, Kane RS. Proteinassisted solubilization of single-walled carbon nanotubes. Langmuir. 2006;22:13925.
[276] Yoshimura SH, Khan S, Maruyama H, Nakayama Y, Takeyasu K. Fluorescence
Labeling of Carbon Nanotubes and Visualization of a Nanotube-Protein Hybrid
under Fluorescence Microscope. Biomacromolecules. 2011;12:1200-4.
[277] Diao XH, Chen HY, Zhang GL, Zhang FB, Fan XB. Magnetic Carbon Nanotubes
for Protein Separation. J Nanomater. 2012.
[278] Ebbesen TW. Carbon nanotubes : preparation and properties. Boca Raton: CRC
Press; 1997.
[279] Lacerda L, Raffa S, Prato M, Bianco A, Kostarelos K. Cell-penetrating CNTs for
delivery of therapeutics. Nano Today. 2007;2:38-43.
[280] Hedrick SM, Ch'en IL, Alves BN. Intertwined pathways of programmed cell death
in immunity. Immunological reviews. 2010;236:41-53.
[281] Tait SW, Green DR. Mitochondria and cell death: outer membrane
permeabilization and beyond. Nature reviews Molecular cell biology. 2010;11:62132.
[282] Chen X, Tam UC, Czlapinski JL, Lee GS, Rabuka D, Zettl A, et al. Interfacing
carbon nanotubes with living cells. J Am Chem Soc. 2006;128:6292-3.
[283] Sayes CM, Wahi R, Kurian PA, Liu Y, West JL, Ausman KD, et al. Correlating
nanoscale titania structure with toxicity: a cytotoxicity and inflammatory response

138

study with human dermal fibroblasts and human lung epithelial cells. Toxicological
sciences : an official journal of the Society of Toxicology. 2006;92:174-85.
[284] Lacerda L, Bianco A, Prato M, Kostarelos K. Carbon nanotubes as nanomedicines:
from toxicology to pharmacology. Advanced drug delivery reviews. 2006;58:146070.
[285] Anderson JM, Shive MS. Biodegradation and biocompatibility of PLA and PLGA
microspheres. Adv Drug Deliver Rev. 1997;28:5-24.

139

